{"recordsFiltered":48523,"recordsTotal":48523,"next":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&start=30600","previous":"http://fdaaa.trialstracker.net/api/trials/?format=json&length=300&start=30000","results":[{"registry_id":"NCT06113328","publication_url":"https://clinicaltrials.gov/study/NCT06113328","title":"A Phase 2a, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of MK-6194 in Adult Participants With Non-Segmental Vitiligo","has_exemption":false,"start_date":"2023-11-27","completion_date":"2025-03-20","has_results":true,"results_due":true,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06716632","publication_url":"https://clinicaltrials.gov/study/NCT06716632","title":"A Comparative Analysis of Hypocalcemia Incidence in Patients Undergoing Thyroidectomy: Ligasure vs Conventional Ligation of Vessels by Knot Tying","has_exemption":false,"start_date":"2024-04-20","completion_date":"2025-03-20","has_results":true,"results_due":true,"sponsor_name":"Gulab Devi Hospital","sponsor_slug":"gulab-devi-hospital","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06749496","publication_url":"https://clinicaltrials.gov/study/NCT06749496","title":"Evaluation of Delefilcon A and Senofilcon A Daily Disposable Toric Soft Contact Lenses Over One Week of Wear","has_exemption":false,"start_date":"2025-01-07","completion_date":"2025-03-20","has_results":false,"results_due":true,"sponsor_name":"Johnson & Johnson Vision Care, Inc.","sponsor_slug":"johnson-johnson-vision-care-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03920267","publication_url":"https://clinicaltrials.gov/study/NCT03920267","title":"A Multi-Center Study to Characterize the Long-Term Safety and Efficacy of BMS-986165 in Subjects With Systemic Lupus Erythematosus","has_exemption":false,"start_date":"2019-03-26","completion_date":"2025-03-21","has_results":true,"results_due":true,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04287049","publication_url":"https://clinicaltrials.gov/study/NCT04287049","title":"Early Bactericidal Activity of Standard Drugs Used to Treat Mycobacterium Avium Complex: a Pilot Study","has_exemption":true,"start_date":"2020-02-24","completion_date":"2025-03-21","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04609878","publication_url":"https://clinicaltrials.gov/study/NCT04609878","title":"A Randomized, Double-Blind, Double Dummy, Parallel Group, Multicenter Variable Length Study to Assess the Efficacy and Safety of PT010 Relative to PT009 and Symbicort® in Adult and Adolescent Participants With Inadequately Controlled Asthma","has_exemption":false,"start_date":"2020-12-15","completion_date":"2025-03-21","has_results":false,"results_due":true,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04817761","publication_url":"https://clinicaltrials.gov/study/NCT04817761","title":"SPARK-ALL: A Multi-center, Open-label, Single-arm Phase 2/3 Trial Evaluating the Safety and Pharmacokinetics of Calaspargase Pegol for Treatment of Adults Aged 22 To >65 Years With Newly-diagnosed Philadelphia-negative ALL.","has_exemption":false,"start_date":"2021-07-07","completion_date":"2025-03-21","has_results":false,"results_due":true,"sponsor_name":"Institut de Recherches Internationales Servier","sponsor_slug":"institut-de-recherches-internationales-servier","status":"reported-late","is_pact":false,"days_late":10},{"registry_id":"NCT05061823","publication_url":"https://clinicaltrials.gov/study/NCT05061823","title":"An Open-label, Multicenter Follow-up Study to Collect Long-term Data on Participants From Multiple Bintrafusp Alfa (M7824) Clinical Studies","has_exemption":false,"start_date":"2021-12-01","completion_date":"2025-03-21","has_results":true,"results_due":true,"sponsor_name":"EMD Serono Research & Development Institute, Inc.","sponsor_slug":"emd-serono-research-development-institute-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05516992","publication_url":"https://clinicaltrials.gov/study/NCT05516992","title":"A Phase 3, Multi-center, Randomized, Double-blind, Placebo-controlled Study, to Evaluate the Safety and Efficacy of SB-01 For Injection for the Treatment of Lumbar Degenerative Disc Disease","has_exemption":false,"start_date":"2022-08-19","completion_date":"2025-03-21","has_results":false,"results_due":true,"sponsor_name":"Spine BioPharma, Inc","sponsor_slug":"spine-biopharma-inc","status":"overdue","is_pact":false,"days_late":32},{"registry_id":"NCT04606264","publication_url":"https://clinicaltrials.gov/study/NCT04606264","title":"Randomized, Embedded, Multifactorial Adaptive Platform for Perioperative Medicine at UPMC (UPMC REMAP): Core Protocol - Enhanced Recovery Protocols (ERP)","has_exemption":false,"start_date":"2023-05-15","completion_date":"2025-03-21","has_results":false,"results_due":true,"sponsor_name":"Jennifer Holder-Murray","sponsor_slug":"jennifer-holder-murray","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05984238","publication_url":"https://clinicaltrials.gov/study/NCT05984238","title":"Endoscopic Application of Pulsed Electric Fields Using by the Endogenex Generation 2 ReCET System for Duodenal Mucosal Regeneration for EliMination of INsulin in the treatmENT of Type 2 Diabetes: a Randomized Double-blind Sham Controlled Trial to Evaluate Safety, Feasibility and Efficacy Study","has_exemption":false,"start_date":"2023-08-03","completion_date":"2025-03-21","has_results":false,"results_due":true,"sponsor_name":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","sponsor_slug":"academisch-medisch-centrum-universiteit-van-amsterdam-amc-uva","status":"overdue","is_pact":false,"days_late":32},{"registry_id":"NCT05572021","publication_url":"https://clinicaltrials.gov/study/NCT05572021","title":"A Comparison of the Outcomes in Fortiva and Strattice Mesh","has_exemption":false,"start_date":"2023-09-25","completion_date":"2025-03-21","has_results":true,"results_due":true,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06544694","publication_url":"https://clinicaltrials.gov/study/NCT06544694","title":"A Phase 3b Study to Investigate the Effect of 0.003% AR-15512 on the Ocular Surface Characteristics of Subjects With Dry Eye Disease","has_exemption":false,"start_date":"2024-10-08","completion_date":"2025-03-21","has_results":true,"results_due":true,"sponsor_name":"Alcon Research","sponsor_slug":"alcon-research","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05052268","publication_url":"https://clinicaltrials.gov/study/NCT05052268","title":"A First-in-Human, Multicenter, Phase 1/2, Open-Label Study of XTX202 in Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2022-01-18","completion_date":"2025-03-22","has_results":false,"results_due":true,"sponsor_name":"Xilio Development, Inc.","sponsor_slug":"xilio-development-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT02645487","publication_url":"https://clinicaltrials.gov/study/NCT02645487","title":"A Phase I Dose-Escalation Study of Stereotactic Radiosurgery for Brain Metastasis Without Whole Brain Radiation","has_exemption":false,"start_date":"2015-12-18","completion_date":"2025-03-23","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT06834295","publication_url":"https://clinicaltrials.gov/study/NCT06834295","title":"An Open-label, Single-dose Study To Assess the Mass Balance Recovery, Metabolite Profile and Metabolite Identification of [14C]Vapendavir in Healthy Male Subjects","has_exemption":false,"start_date":"2025-03-12","completion_date":"2025-03-23","has_results":false,"results_due":false,"sponsor_name":"Altesa Biosciences, Inc.","sponsor_slug":"altesa-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02881320","publication_url":"https://clinicaltrials.gov/study/NCT02881320","title":"A Phase 2/3, Open-Label Study of the Pharmacokinetics, Safety, and Antiviral Activity of the GS-9883/Emtricitabine/Tenofovir Alafenamide (GS-9883/F/TAF) Fixed Dose Combination (FDC) in HIV-1 Infected Adolescents and Children","has_exemption":true,"start_date":"2016-09-21","completion_date":"2025-03-24","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03784066","publication_url":"https://clinicaltrials.gov/study/NCT03784066","title":"Durvalumab (MEDI4736) Plus Tremelimumab in Resectable, Locally Advanced Squamous Cell Carcinoma of the Oral Cavity: a Window of Opportunity Study","has_exemption":false,"start_date":"2018-08-27","completion_date":"2025-03-24","has_results":false,"results_due":false,"sponsor_name":"Universitaire Ziekenhuizen KU Leuven","sponsor_slug":"universitaire-ziekenhuizen-ku-leuven","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04450693","publication_url":"https://clinicaltrials.gov/study/NCT04450693","title":"A Multicenter Phase 3 Confirmatory Trial of Biotherapy Using Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU II)","has_exemption":false,"start_date":"2020-11-20","completion_date":"2025-03-24","has_results":false,"results_due":false,"sponsor_name":"BioTissue Holdings, Inc","sponsor_slug":"biotissue-holdings-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05355597","publication_url":"https://clinicaltrials.gov/study/NCT05355597","title":"\"The Efficacy of Exparel Versus a Multidrug Cocktail in Soft Tissue Tumors\"","has_exemption":false,"start_date":"2021-01-27","completion_date":"2025-03-24","has_results":false,"results_due":false,"sponsor_name":"Atlantic Health System","sponsor_slug":"atlantic-health-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04988022","publication_url":"https://clinicaltrials.gov/study/NCT04988022","title":"Defining Reversal of Keloid Lesions by Th2 Targeting With Dupilumab Treatment","has_exemption":false,"start_date":"2021-05-25","completion_date":"2025-03-24","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05257408","publication_url":"https://clinicaltrials.gov/study/NCT05257408","title":"A Phase 3 Study of Relacorilant in Combination With Nab-Paclitaxel Versus Nab-Paclitaxel Monotherapy in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer (ROSELLA)","has_exemption":false,"start_date":"2022-06-29","completion_date":"2025-03-24","has_results":false,"results_due":false,"sponsor_name":"Corcept Therapeutics","sponsor_slug":"corcept-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05398263","publication_url":"https://clinicaltrials.gov/study/NCT05398263","title":"A Randomised, Double-Blind, Parallel-Group, Placebo-Controlled 28-week Phase 3 Efficacy and Safety Study of Tezepelumab in Reducing Oral Corticosteroid Use in Adults With Oral Corticosteroid Dependent Asthma (SUNRISE)","has_exemption":false,"start_date":"2022-08-09","completion_date":"2025-03-24","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05975619","publication_url":"https://clinicaltrials.gov/study/NCT05975619","title":"A Prospective Imaging Study of Target Definition and Radiation Planning Workflows on the Integrated TrueBeam-HyperSight System for Patients Receiving Radiation Therapy","has_exemption":false,"start_date":"2023-08-29","completion_date":"2025-03-24","has_results":false,"results_due":false,"sponsor_name":"Varian, a Siemens Healthineers Company","sponsor_slug":"varian-a-siemens-healthineers-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05558696","publication_url":"https://clinicaltrials.gov/study/NCT05558696","title":"A Phase 2 Multi-Center, Open Label Study to Assess the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Bomedemstat in Patients With Polycythemia Vera (PV)","has_exemption":false,"start_date":"2023-09-07","completion_date":"2025-03-24","has_results":false,"results_due":false,"sponsor_name":"Imago BioSciences, Inc., a subsidiary of Merck & Co., Inc., (Rahway, New Jersey USA)","sponsor_slug":"imago-biosciences-inc-a-subsidiary-of-merck-co-inc-rahway-new-jersey-usa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06603623","publication_url":"https://clinicaltrials.gov/study/NCT06603623","title":"Phase 2 Double-Blind, Randomized, Placebo Controlled, Efficacy and Safety Trial of BHV-2100 for the Acute Treatment of Migraine","has_exemption":true,"start_date":"2024-10-10","completion_date":"2025-03-24","has_results":false,"results_due":false,"sponsor_name":"Biohaven Therapeutics Ltd.","sponsor_slug":"biohaven-therapeutics-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03644667","publication_url":"https://clinicaltrials.gov/study/NCT03644667","title":"Targeting Inflammation and Alloimmunity in Heart Transplant Recipients With Tocilizumab (RTB-004)","has_exemption":true,"start_date":"2018-12-20","completion_date":"2025-03-25","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03475186","publication_url":"https://clinicaltrials.gov/study/NCT03475186","title":"A Single Arm, Pilot Study of Ramipril for Preventing Radiation-Induced Cognitive Decline in Glioblastoma (GBM) Patients Receiving Brain Radiotherapy","has_exemption":false,"start_date":"2019-03-25","completion_date":"2025-03-25","has_results":true,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04435691","publication_url":"https://clinicaltrials.gov/study/NCT04435691","title":"An Open-Label Phase IB/II Study of Magrolimab in Combination With Azacitidine and Venetoclax for the Treatment of Patients With Acute Myeloid Leukemia (AML)","has_exemption":false,"start_date":"2020-07-28","completion_date":"2025-03-25","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04834414","publication_url":"https://clinicaltrials.gov/study/NCT04834414","title":"CHIlled Platelet Study","has_exemption":false,"start_date":"2021-10-21","completion_date":"2025-03-25","has_results":false,"results_due":false,"sponsor_name":"Philip Spinella","sponsor_slug":"philip-spinella","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05843864","publication_url":"https://clinicaltrials.gov/study/NCT05843864","title":"Utilizing Photobiomodulation Therapy for the Treatment of Lower Extremity Stress Fractures in a Military Training Setting","has_exemption":false,"start_date":"2023-06-07","completion_date":"2025-03-25","has_results":false,"results_due":false,"sponsor_name":"Brooke Army Medical Center","sponsor_slug":"brooke-army-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06176794","publication_url":"https://clinicaltrials.gov/study/NCT06176794","title":"A Crossover Study of Patients With Heart Failure to Compare Natriuretic Effects of Immediate Release Torsemide vs. Extended Release Torsemide Over 12 Hours After Dosing","has_exemption":false,"start_date":"2024-11-15","completion_date":"2025-03-25","has_results":false,"results_due":false,"sponsor_name":"Sarfez Pharmaceuticals, Inc.","sponsor_slug":"sarfez-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06708611","publication_url":"https://clinicaltrials.gov/study/NCT06708611","title":"A Crossover Study to Compare Natriuretic Effects of Extended Release Torsemide to Immediate Release Torsemide Over 12 Hours After Dosing in Patients with Heart Failure (EXTOR-HF)","has_exemption":false,"start_date":"2025-01-15","completion_date":"2025-03-25","has_results":false,"results_due":false,"sponsor_name":"Sarfez Pharmaceuticals, Inc.","sponsor_slug":"sarfez-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03894215","publication_url":"https://clinicaltrials.gov/study/NCT03894215","title":"A Two-arm, Randomized, Non-comparative, Phase 2 Trial of AGEN2034 (Anti-PD-1) as a Monotherapy or Combination Therapy With AGEN1884 (Anti- CTLA4) or With Placebo in Women With Recurrent Cervical Cancer (Second Line) - RaPiDS","has_exemption":true,"start_date":"2019-06-01","completion_date":"2025-03-26","has_results":false,"results_due":false,"sponsor_name":"Agenus Inc.","sponsor_slug":"agenus-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04314544","publication_url":"https://clinicaltrials.gov/study/NCT04314544","title":"A Phase III, Randomized, Double-Blind, Single-Dose, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Tildrakizumab in Subjects With Active Psoriatic Arthritis I (INSPIRE 1)","has_exemption":false,"start_date":"2020-07-01","completion_date":"2025-03-26","has_results":false,"results_due":false,"sponsor_name":"Sun Pharmaceutical Industries Limited","sponsor_slug":"sun-pharmaceutical-industries-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04564339","publication_url":"https://clinicaltrials.gov/study/NCT04564339","title":"A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ravulizumab in Adult Participants With Proliferative Lupus Nephritis (LN) or Immunoglobulin A Nephropathy (IgAN)","has_exemption":false,"start_date":"2021-01-19","completion_date":"2025-03-26","has_results":true,"results_due":false,"sponsor_name":"Alexion Pharmaceuticals, Inc.","sponsor_slug":"alexion-pharmaceuticals-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05524051","publication_url":"https://clinicaltrials.gov/study/NCT05524051","title":"A Randomized, Multi-centric, Placebo-controlled, Participant and Investigator-blinded Study to Evaluate the Safety, Tolerability and Efficacy of TIN816 in Adult Patients at Risk for Acute Kidney Injury Following Cardiac Surgery.","has_exemption":false,"start_date":"2023-03-03","completion_date":"2025-03-26","has_results":true,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05907122","publication_url":"https://clinicaltrials.gov/study/NCT05907122","title":"A Randomized, Double-blind Study Evaluating Pharmacokinetic Similarity of ABP 206 Compared With OPDIVO® (Nivolumab) in Resected Stage III or Stage IV Melanoma Subjects in the Adjuvant Setting","has_exemption":true,"start_date":"2023-07-26","completion_date":"2025-03-26","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06364748","publication_url":"https://clinicaltrials.gov/study/NCT06364748","title":"Expanding Access to Care Through Telemedical Support for Vital Sign Monitoring in High-risk Patients With Cancer","has_exemption":false,"start_date":"2024-03-11","completion_date":"2025-03-26","has_results":false,"results_due":false,"sponsor_name":"West Michigan Cancer Center","sponsor_slug":"west-michigan-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06436183","publication_url":"https://clinicaltrials.gov/study/NCT06436183","title":"A Phase 2a, Multicenter, Randomized, Double-blind, 16-week Placebo-controlled Study With an Open Label Extension to Evaluate the Efficacy and Safety of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis","has_exemption":false,"start_date":"2024-05-01","completion_date":"2025-03-26","has_results":false,"results_due":false,"sponsor_name":"Apollo Therapeutics Ltd","sponsor_slug":"apollo-therapeutics-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02228889","publication_url":"https://clinicaltrials.gov/study/NCT02228889","title":"Prospective Trial Comparing the Performance Profiles of Two Non-Cross-Linked Porcine Dermal Matrices in Abdominal Wall Reconstruction","has_exemption":false,"start_date":"2015-01-31","completion_date":"2025-03-27","has_results":true,"results_due":false,"sponsor_name":"Jeffrey Janis","sponsor_slug":"jeffrey-janis","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT05228184","publication_url":"https://clinicaltrials.gov/study/NCT05228184","title":"A Randomized Comparative Study Between Liquid (Tirosint®-SOL) and Tablet Formulations of Levothyroxine in Neonates and Infants With Congenital Hypothyroidism","has_exemption":false,"start_date":"2022-01-21","completion_date":"2025-03-27","has_results":false,"results_due":false,"sponsor_name":"IBSA Institut Biochimique SA","sponsor_slug":"ibsa-institut-biochimique-sa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05482022","publication_url":"https://clinicaltrials.gov/study/NCT05482022","title":"Speaking Valve Influence on Breathing, Swallowing and Vocal Functions in Patients With Tracheostomy.","has_exemption":false,"start_date":"2022-08-01","completion_date":"2025-03-27","has_results":false,"results_due":false,"sponsor_name":"Loewenstein Hospital","sponsor_slug":"loewenstein-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05147805","publication_url":"https://clinicaltrials.gov/study/NCT05147805","title":"A Phase 2b, Randomized, Double-Blind, Multicenter, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial Hypertension","has_exemption":true,"start_date":"2022-08-24","completion_date":"2025-03-27","has_results":false,"results_due":false,"sponsor_name":"Insmed Incorporated","sponsor_slug":"insmed-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05090384","publication_url":"https://clinicaltrials.gov/study/NCT05090384","title":"Serial Response and Biomarker-Guided Steroid Taper for Children With GVHD","has_exemption":false,"start_date":"2022-10-20","completion_date":"2025-03-27","has_results":false,"results_due":false,"sponsor_name":"John Levine","sponsor_slug":"john-levine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05224063","publication_url":"https://clinicaltrials.gov/study/NCT05224063","title":"CRCNS US-France Research Proposal: Probing the Dorsolateral Prefrontal Cortex and Central Executive Network for Improving Neuromodulation in Depression","has_exemption":false,"start_date":"2023-01-01","completion_date":"2025-03-27","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03737643","publication_url":"https://clinicaltrials.gov/study/NCT03737643","title":"A Phase III Randomised, Double-Blind, Placebo-Controlled, Multicentre Study of Durvalumab in Combination With Chemotherapy and Bevacizumab, Followed by Maintenance Durvalumab, Bevacizumab and Olaparib in Newly Diagnosed Advanced Ovarian Cancer Patients (DUO-O).","has_exemption":false,"start_date":"2019-01-04","completion_date":"2025-03-28","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04563078","publication_url":"https://clinicaltrials.gov/study/NCT04563078","title":"Effect of Transcranial Magnetic Stimulation (TMS) on PTSD Neuroimaging and Psychophysiological Biomarkers","has_exemption":false,"start_date":"2021-02-15","completion_date":"2025-03-28","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05673811","publication_url":"https://clinicaltrials.gov/study/NCT05673811","title":"A Phase IIb, Open-label, Randomized Study of Nab-Paclitaxel and Gemcitabine and Plus/Minus VCN-01 in Patients With Metastatic Pancreatic Cancer","has_exemption":false,"start_date":"2023-01-10","completion_date":"2025-03-28","has_results":false,"results_due":false,"sponsor_name":"Theriva Biologics SL","sponsor_slug":"theriva-biologics-sl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05870540","publication_url":"https://clinicaltrials.gov/study/NCT05870540","title":"A Quadruple Masked, Dose-Finding Study to Evaluate the Efficacy and Safety of Intranasal BPL-003, With Open Label Extension, in Patients With Treatment-Resistant Depression","has_exemption":false,"start_date":"2023-09-14","completion_date":"2025-03-28","has_results":false,"results_due":false,"sponsor_name":"Beckley Psytech Limited","sponsor_slug":"beckley-psytech-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05980598","publication_url":"https://clinicaltrials.gov/study/NCT05980598","title":"BelieveIT-201: Phase 2, Randomized Open-labeled Trial of TransCon (TC) TLR7/8 Agonist in Combination With Pembrolizumab or With TC IL-2 β/γ, or Pembrolizumab Alone as Neoadjuvant Therapy for Stage III-IVA Resectable Locoregionally Advanced Head and Neck Squamous Cell Carcinoma","has_exemption":false,"start_date":"2023-09-29","completion_date":"2025-03-28","has_results":false,"results_due":false,"sponsor_name":"Ascendis Pharma A/S","sponsor_slug":"ascendis-pharma-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06227546","publication_url":"https://clinicaltrials.gov/study/NCT06227546","title":"A Phase II Study of MGC018 in Patients With Relapsed or Refractory Extensive-Stage Small-Cell Lung Cancer (ES-SCLC)","has_exemption":false,"start_date":"2024-04-15","completion_date":"2025-03-28","has_results":true,"results_due":false,"sponsor_name":"Georgetown University","sponsor_slug":"georgetown-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06502977","publication_url":"https://clinicaltrials.gov/study/NCT06502977","title":"Phase 2a Study Evaluating the Efficacy, Safety, Tolerability and Pharmacokinetics of Tarlatamab in Chinese Subjects With Advanced Small Cell Lung Cancer After Two or More Prior Lines of Treatment (DeLLphi-307)","has_exemption":false,"start_date":"2024-08-27","completion_date":"2025-03-28","has_results":true,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06993090","publication_url":"https://clinicaltrials.gov/study/NCT06993090","title":"Efficacy of the Dorsal Application of Kinesio Tape on Esport Gamers","has_exemption":false,"start_date":"2025-01-22","completion_date":"2025-03-28","has_results":false,"results_due":false,"sponsor_name":"University of Nevada, Las Vegas","sponsor_slug":"university-of-nevada-las-vegas","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02996721","publication_url":"https://clinicaltrials.gov/study/NCT02996721","title":"A Trial Evaluating Vitamin D Normalization on Major Adverse Cardiovascular-Related Events Among Myocardial Infarction Patients (The TARGET-D Study)","has_exemption":false,"start_date":"2017-04-03","completion_date":"2025-03-30","has_results":false,"results_due":false,"sponsor_name":"Intermountain Health Care, Inc.","sponsor_slug":"intermountain-health-care-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04183205","publication_url":"https://clinicaltrials.gov/study/NCT04183205","title":"An Electrophysiological Predictor of SSRI Response in Veterans With PTSD","has_exemption":false,"start_date":"2019-09-11","completion_date":"2025-03-30","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04339738","publication_url":"https://clinicaltrials.gov/study/NCT04339738","title":"A Multicenter Phase II Trial of Paclitaxel With and Without Nivolumab in Taxane Naive, and Nivolumab and Cabozantinib in Taxane Pretreated Subjects With Angiosarcoma","has_exemption":false,"start_date":"2020-11-04","completion_date":"2025-03-30","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04497012","publication_url":"https://clinicaltrials.gov/study/NCT04497012","title":"Enteral Iron Supplementation and Intestinal Health in Preterm Infants","has_exemption":false,"start_date":"2020-11-17","completion_date":"2025-03-30","has_results":false,"results_due":false,"sponsor_name":"University of South Florida","sponsor_slug":"university-of-south-florida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04857983","publication_url":"https://clinicaltrials.gov/study/NCT04857983","title":"Memantine Augmentation of Targeted Cognitive Training in Schizophrenia","has_exemption":false,"start_date":"2021-07-06","completion_date":"2025-03-30","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04776239","publication_url":"https://clinicaltrials.gov/study/NCT04776239","title":"Allogeneic Mesenchymal Human Stem Cell Infusion Therapy for Endothelial DySfunctiOn in Diabetic Subjects With Symptomatic Ischemic Heart Disease.","has_exemption":false,"start_date":"2021-08-16","completion_date":"2025-03-30","has_results":false,"results_due":false,"sponsor_name":"Joshua M Hare","sponsor_slug":"joshua-m-hare","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05131139","publication_url":"https://clinicaltrials.gov/study/NCT05131139","title":"Enhance Study: A Prospective, Multicenter Evaluation of Accuracy and Safety of the Eversense CGM System With Enhanced Features","has_exemption":false,"start_date":"2021-10-20","completion_date":"2025-03-30","has_results":false,"results_due":false,"sponsor_name":"Senseonics, Inc.","sponsor_slug":"senseonics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05301478","publication_url":"https://clinicaltrials.gov/study/NCT05301478","title":"Patient Specific 3D Printed Diabetic Insoles to Reduce Plantar Pressure","has_exemption":false,"start_date":"2022-03-01","completion_date":"2025-03-30","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04896073","publication_url":"https://clinicaltrials.gov/study/NCT04896073","title":"A Phase II Trial of the Superenhancer Inhibitor Minnelide in Advanced Refractory Adenosquamous Carcinoma of the Pancreas (ASCP)","has_exemption":false,"start_date":"2022-03-07","completion_date":"2025-03-30","has_results":true,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05433025","publication_url":"https://clinicaltrials.gov/study/NCT05433025","title":"Safety and Treatment Effect of a Novel Device for Neck Pain in Active-duty Military Personnel With Forward Head Posture.","has_exemption":false,"start_date":"2022-06-20","completion_date":"2025-03-30","has_results":false,"results_due":false,"sponsor_name":"Kessler Foundation","sponsor_slug":"kessler-foundation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05567757","publication_url":"https://clinicaltrials.gov/study/NCT05567757","title":"Initial Safety Study of the TRUE AVC in Hemodialysis Access (TRUE AVC I Study)","has_exemption":false,"start_date":"2022-10-04","completion_date":"2025-03-30","has_results":false,"results_due":false,"sponsor_name":"Vascudyne, Inc.","sponsor_slug":"vascudyne-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05349240","publication_url":"https://clinicaltrials.gov/study/NCT05349240","title":"A Prospective, Single-arm, Multicenter Study to Evaluate the Efficacy and Safety of C2 CryoBalloonTM Ablation System in Patients With Esophageal Squamous Epithelium Dysplasia","has_exemption":false,"start_date":"2022-11-18","completion_date":"2025-03-30","has_results":false,"results_due":false,"sponsor_name":"Pentax Medical","sponsor_slug":"pentax-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06449482","publication_url":"https://clinicaltrials.gov/study/NCT06449482","title":"An Exploratory Clinical Study of Selinexor Combined With Venetoclax and Azactidine in the Treatment of Acute Myeloid Leukemia Patients Who Are Not Eligible for Intense Chemotherapy Regimen at Initial Treatment","has_exemption":false,"start_date":"2023-05-05","completion_date":"2025-03-30","has_results":false,"results_due":false,"sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","sponsor_slug":"institute-of-hematology-blood-diseases-hospital-china","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06027749","publication_url":"https://clinicaltrials.gov/study/NCT06027749","title":"Impact of Capturing Ictal Events With Ultra-long-term Ambulatory EEG Monitoring With REMI.","has_exemption":false,"start_date":"2023-10-13","completion_date":"2025-03-30","has_results":false,"results_due":false,"sponsor_name":"Epitel, Inc.","sponsor_slug":"epitel-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05922033","publication_url":"https://clinicaltrials.gov/study/NCT05922033","title":"Patient Versus Provider-led Titration of Insulin for Glycemic Control in Gestational Diabetes","has_exemption":false,"start_date":"2023-10-19","completion_date":"2025-03-30","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06149494","publication_url":"https://clinicaltrials.gov/study/NCT06149494","title":"A Trial in Participants With Chronic Obstructive Pulmonary Disease (COPD) to Evaluate the Impact of Vapendavir on the Development of Lower Respiratory Tract Symptoms Following Rhinovirus Challenge","has_exemption":false,"start_date":"2023-11-20","completion_date":"2025-03-30","has_results":false,"results_due":false,"sponsor_name":"Altesa Biosciences, Inc.","sponsor_slug":"altesa-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06361446","publication_url":"https://clinicaltrials.gov/study/NCT06361446","title":"Zonisamide Versus Propranolol in Migraine, a Randomized Controlled Single-blinded Trial","has_exemption":false,"start_date":"2024-03-29","completion_date":"2025-03-30","has_results":false,"results_due":false,"sponsor_name":"Kafrelsheikh University","sponsor_slug":"kafrelsheikh-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06344416","publication_url":"https://clinicaltrials.gov/study/NCT06344416","title":"Study of Ribociclib (Ribo) Treatment Adherence Clinical Study Protocol","has_exemption":false,"start_date":"2024-03-30","completion_date":"2025-03-30","has_results":false,"results_due":false,"sponsor_name":"Dosentrx Ltd.","sponsor_slug":"dosentrx-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07306403","publication_url":"https://clinicaltrials.gov/study/NCT07306403","title":"THE COMPARISON OF GELATIN SPONGE TO SUTURE ALONE ON POST OPERATIVE SWELLING AFTER EXTRACTION OF IMPACTED MANDIBULAR THIRD MOLAR.","has_exemption":false,"start_date":"2024-08-30","completion_date":"2025-03-30","has_results":false,"results_due":false,"sponsor_name":"Watim Medical & Dental College","sponsor_slug":"watim-medical-dental-college","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06563258","publication_url":"https://clinicaltrials.gov/study/NCT06563258","title":"Efficacy of Biodex Balance Training Versus Whole Body Vibration Training in Patients With Knee Osteoarthritis","has_exemption":false,"start_date":"2024-09-01","completion_date":"2025-03-30","has_results":false,"results_due":false,"sponsor_name":"Cairo University","sponsor_slug":"cairo-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06612281","publication_url":"https://clinicaltrials.gov/study/NCT06612281","title":"Evaluation of Gixam's Performance in a FIT Negative Population","has_exemption":false,"start_date":"2024-11-01","completion_date":"2025-03-30","has_results":false,"results_due":false,"sponsor_name":"Jubaan Ltd.","sponsor_slug":"jubaan-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04194476","publication_url":"https://clinicaltrials.gov/study/NCT04194476","title":"Performance Study of Nova StatStrip® Blood Glucose Monitoring Test System on Neonatal Capillary Blood","has_exemption":false,"start_date":"2025-01-01","completion_date":"2025-03-30","has_results":false,"results_due":false,"sponsor_name":"Nova Biomedical","sponsor_slug":"nova-biomedical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06757062","publication_url":"https://clinicaltrials.gov/study/NCT06757062","title":"Less Pain, More Game: Efficacy of Red Kinesiology Tape on Carpal Tunnel-Like Symptoms and Performance in Esports Gamers","has_exemption":false,"start_date":"2025-01-01","completion_date":"2025-03-30","has_results":false,"results_due":false,"sponsor_name":"University of Nevada, Las Vegas","sponsor_slug":"university-of-nevada-las-vegas","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06782035","publication_url":"https://clinicaltrials.gov/study/NCT06782035","title":"The Influence of Periodontal Dressings (Ora-Aid) and Various Materials on the Donor Site's Quality of Life After Free Gingival Graft Surgery","has_exemption":false,"start_date":"2025-01-02","completion_date":"2025-03-30","has_results":false,"results_due":false,"sponsor_name":"Izmir Katip Celebi University","sponsor_slug":"izmir-katip-celebi-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01897688","publication_url":"https://clinicaltrials.gov/study/NCT01897688","title":"A Phase 3 Single Center Study of Islet Transplantation in Non-uremic Diabetic Patients","has_exemption":false,"start_date":"2012-06-30","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01627821","publication_url":"https://clinicaltrials.gov/study/NCT01627821","title":"Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study","has_exemption":false,"start_date":"2013-02-28","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Jarvik Heart, Inc.","sponsor_slug":"jarvik-heart-inc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01937949","publication_url":"https://clinicaltrials.gov/study/NCT01937949","title":"Clinical Outcomes and Quality of Life Measures in Patients Treated for Complex Abdominal Aortic Aneurysms With Fenestrated Stent Grafts","has_exemption":false,"start_date":"2013-08-31","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Gustavo S. Oderich","sponsor_slug":"gustavo-s-oderich","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02413970","publication_url":"https://clinicaltrials.gov/study/NCT02413970","title":"Inspire® Upper Airway Stimulation System (UAS): Post-Approval Study Protocol Number 2014-001","has_exemption":false,"start_date":"2015-05-31","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Inspire Medical Systems, Inc.","sponsor_slug":"inspire-medical-systems-inc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02446457","publication_url":"https://clinicaltrials.gov/study/NCT02446457","title":"Phase II Study of Rituximab Plus Pembrolizumab (MK-3475) in Subjects With Relapsed Follicular Lymphoma","has_exemption":false,"start_date":"2015-07-31","completion_date":"2025-03-31","has_results":true,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02521103","publication_url":"https://clinicaltrials.gov/study/NCT02521103","title":"A Prospective, Post-market, Multi-center Evaluation of the Clinical Outcomes of the Triathlon TS Total Knee System With Triathlon Tritanium Cone Augments","has_exemption":false,"start_date":"2015-08-31","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Stryker Orthopaedics","sponsor_slug":"stryker-orthopaedics","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03007732","publication_url":"https://clinicaltrials.gov/study/NCT03007732","title":"Phase 2 Trial Pembrolizumab or Pembrolizumab in Combination With Intratumoral SD-101 Therapy in Patients With Hormone-Naïve Oligometastatic Prostate Cancer Receiving Stereotactic Body Radiation Therapy and Intermittent Androgen Deprivation Therapy","has_exemption":false,"start_date":"2017-05-17","completion_date":"2025-03-31","has_results":true,"results_due":false,"sponsor_name":"David Oh","sponsor_slug":"david-oh","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03155620","publication_url":"https://clinicaltrials.gov/study/NCT03155620","title":"NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol","has_exemption":false,"start_date":"2017-07-31","completion_date":"2025-03-31","has_results":true,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03364153","publication_url":"https://clinicaltrials.gov/study/NCT03364153","title":"A Phase 2b Randomized, Double-masked, Controlled Trial to Establish the Safety and Efficacy of Zimura™ (Complement C5 Inhibitor) Compared to Sham in Subjects With Autosomal Recessive Stargardt Disease","has_exemption":false,"start_date":"2018-01-12","completion_date":"2025-03-31","has_results":true,"results_due":false,"sponsor_name":"Astellas Pharma Global Development, Inc.","sponsor_slug":"astellas-pharma-global-development-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03317392","publication_url":"https://clinicaltrials.gov/study/NCT03317392","title":"A Phase 1/2 Study of Combination Olaparib and Radium-223 in Men With Metastatic Castration-Resistant Prostate Cancer With Bone Metastases (COMRADE)","has_exemption":false,"start_date":"2019-02-04","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03858985","publication_url":"https://clinicaltrials.gov/study/NCT03858985","title":"Vagal Nerve Stimulation to Probe Inflammation and Brain in Post-traumatic Stress","has_exemption":false,"start_date":"2019-02-04","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03789097","publication_url":"https://clinicaltrials.gov/study/NCT03789097","title":"In Situ Vaccination With Flt3L, Radiation, and Poly-ICLC Combined With Pembrolizumab in Patients With Non-Hodgkin's Lymphoma, Metastatic Breast Cancer, and Head and Neck Squamous Cell Carcinoma","has_exemption":false,"start_date":"2019-04-05","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04053803","publication_url":"https://clinicaltrials.gov/study/NCT04053803","title":"An Open-label Extension Study of IMR-687 in Adult Patients With Sickle Cell Anemia (Homozygous HbSS or Sickle-β0 Thalassemia) Who Participated in Study IMR-SCD-102","has_exemption":false,"start_date":"2019-05-22","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Imara, Inc.","sponsor_slug":"imara-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03794349","publication_url":"https://clinicaltrials.gov/study/NCT03794349","title":"A Phase 2 Randomized Study of Irinotecan/Temozolomide/Dinutuximab With or Without Eflornithine (DFMO) in Children With Relapsed, Refractory or Progressive Neuroblastoma","has_exemption":false,"start_date":"2019-07-08","completion_date":"2025-03-31","has_results":true,"results_due":false,"sponsor_name":"Children's Oncology Group","sponsor_slug":"childrens-oncology-group","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03916627","publication_url":"https://clinicaltrials.gov/study/NCT03916627","title":"A Multi-Cohort Exploratory Study of Neoadjuvant Cemiplimab for the Treatment of Resectable NSCLC, HCC, and HNSCC","has_exemption":true,"start_date":"2019-07-23","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04121780","publication_url":"https://clinicaltrials.gov/study/NCT04121780","title":"Interventional Study of Growth Hormone Replacement Therapy in Retired Professional Football Players With Growth Hormone Deficiency","has_exemption":false,"start_date":"2019-10-08","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Center for Neurological Studies","sponsor_slug":"center-for-neurological-studies","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04195555","publication_url":"https://clinicaltrials.gov/study/NCT04195555","title":"NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) - Phase 2 Subprotocol of AG-120 (Ivosidenib) in Patients With Tumors Harboring IDH1 Mutations","has_exemption":false,"start_date":"2020-07-20","completion_date":"2025-03-31","has_results":true,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04363801","publication_url":"https://clinicaltrials.gov/study/NCT04363801","title":"A Phase 2, Multicenter, Open-Label Study of DKN-01 in Combination With Tislelizumab ± Chemotherapy as First-Line or Second-Line Therapy in Adult Patients With Inoperable, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma (DisTinGuish)","has_exemption":false,"start_date":"2020-07-29","completion_date":"2025-03-31","has_results":true,"results_due":false,"sponsor_name":"Leap Therapeutics, Inc.","sponsor_slug":"leap-therapeutics-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04372797","publication_url":"https://clinicaltrials.gov/study/NCT04372797","title":"Standardized Instruments to Provide Diagnostic and Prognostic Information in Mild Traumatic Brain Injury (mTBI)","has_exemption":false,"start_date":"2020-09-30","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Carey Balaban","sponsor_slug":"carey-balaban","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04628481","publication_url":"https://clinicaltrials.gov/study/NCT04628481","title":"Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Assess Effect and Safety of 400 mg Twice a Day Oral Ladarixin in Patients With Recent Onset Type 1 Diabetes and Low Residual β-cell Function at Baseline (GLADIATOR)","has_exemption":false,"start_date":"2021-01-12","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Dompé Farmaceutici S.p.A","sponsor_slug":"dompe-farmaceutici-spa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04230499","publication_url":"https://clinicaltrials.gov/study/NCT04230499","title":"Phase IIA Trial of Encapsulated Rapamycin (eRapa) to Prevent Progression in Familial Adenomatous Polyposis Patients Under Active Surveillance","has_exemption":false,"start_date":"2021-01-18","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Rapamycin Holdings Inc.","sponsor_slug":"rapamycin-holdings-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01590862","publication_url":"https://clinicaltrials.gov/study/NCT01590862","title":"ON/OFF Stimulation and Reward Motivation in Patients With Deep Brain Stimulators","has_exemption":false,"start_date":"2021-01-23","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04761705","publication_url":"https://clinicaltrials.gov/study/NCT04761705","title":"A Phase 1/2 Safety and Efficacy Study of JV-GL1 Applied to the Periorbital Skin in Subjects With Open-Angle Glaucoma or Ocular Hypertension","has_exemption":false,"start_date":"2021-03-10","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"JeniVision, Inc.","sponsor_slug":"jenivision-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04757610","publication_url":"https://clinicaltrials.gov/study/NCT04757610","title":"A Phase 3, Multicentre, Double-masked, Randomised Study to Evaluate the Efficacy and Safety of Intravitreal OPT-302 in Combination With Ranibizumab, Compared With Ranibizumab Alone, in Participants With nAMD","has_exemption":false,"start_date":"2021-03-12","completion_date":"2025-03-31","has_results":true,"results_due":false,"sponsor_name":"Opthea Limited","sponsor_slug":"opthea-limited","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04757636","publication_url":"https://clinicaltrials.gov/study/NCT04757636","title":"A Phase 3, Multicentre, Double-masked, Randomised Study to Evaluate the Efficacy and Safety of Intravitreal OPT-302 in Combination With Aflibercept, Compared With Aflibercept Alone, in Participants With nAMD","has_exemption":false,"start_date":"2021-03-12","completion_date":"2025-03-31","has_results":true,"results_due":false,"sponsor_name":"Opthea Limited","sponsor_slug":"opthea-limited","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04484220","publication_url":"https://clinicaltrials.gov/study/NCT04484220","title":"Ellipsys Vascular Access System Post Market Surveillance (PS) Study PS200001 Reference DEN170004","has_exemption":false,"start_date":"2021-04-13","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Medtronic Endovascular","sponsor_slug":"medtronic-endovascular","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04902872","publication_url":"https://clinicaltrials.gov/study/NCT04902872","title":"A Phase 1/2 Study of CBX-12 in Subjects With Advanced or Metastatic Refractory Solid Tumors","has_exemption":false,"start_date":"2021-05-03","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Cybrexa Therapeutics","sponsor_slug":"cybrexa-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04913922","publication_url":"https://clinicaltrials.gov/study/NCT04913922","title":"An Open-Label Phase II Study of Relatlimab (BMS-986016) With Nivolumab (BMS-936558) in Combination With 5-Azacytidine for the Treatment of Patients With Refractory/Relapsed Acute Myeloid Leukemia and Newly Diagnosed Older Acute Myeloid Leukemia Patients","has_exemption":false,"start_date":"2021-05-05","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Ludwig-Maximilians - University of Munich","sponsor_slug":"ludwig-maximilians-university-of-munich","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06619600","publication_url":"https://clinicaltrials.gov/study/NCT06619600","title":"Effect of Dapagliflozin in Myocardial Fibrosis and Ventricular Function in Patients With a ST-segment Elevation Myocardial Infarction","has_exemption":false,"start_date":"2021-05-30","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Hospital Clinic of Barcelona","sponsor_slug":"hospital-clinic-of-barcelona","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04444622","publication_url":"https://clinicaltrials.gov/study/NCT04444622","title":"Phase IIB Open-Label Study to Assess the Safety and Efficacy of STIMVAX® as Third-line Therapy for Metastatic Colorectal Cancer","has_exemption":false,"start_date":"2021-07-12","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Mirror Biologics, Inc.","sponsor_slug":"mirror-biologics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04780217","publication_url":"https://clinicaltrials.gov/study/NCT04780217","title":"A Phase 1/2a Open-Label Dose Escalation and Dose Expansion Study of T3011 When Administered Intravenously as a Single Agent and in Combination With Other Therapy in Subjects With Advanced Solid Tumors","has_exemption":false,"start_date":"2021-08-10","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"ImmVira Pharma Co. Ltd","sponsor_slug":"immvira-pharma-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05112861","publication_url":"https://clinicaltrials.gov/study/NCT05112861","title":"A 3-month Study to Compare the Safety of ONS-5010 in Vials Versus PFS in Subjects With Visual Impairment Due to Retinal Disorders, NORSE SEVEN","has_exemption":false,"start_date":"2021-11-15","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Outlook Therapeutics, Inc.","sponsor_slug":"outlook-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05072093","publication_url":"https://clinicaltrials.gov/study/NCT05072093","title":"Parrying the Pitfalls of PrEP: Preventing Premature PrEP Discontinuation and STIs Among MSM","has_exemption":false,"start_date":"2021-11-20","completion_date":"2025-03-31","has_results":true,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05082285","publication_url":"https://clinicaltrials.gov/study/NCT05082285","title":"A Phase II, Randomized, Partially Blinded Study to Assess the Safety, Tolerability and Immunogenicity of Meningococcal Combined ABCWY Vaccine When Administered to Healthy Infants","has_exemption":false,"start_date":"2021-11-29","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05199272","publication_url":"https://clinicaltrials.gov/study/NCT05199272","title":"A Phase 1/2a, Multicenter, Open-Label, Dose-Escalation and Expansion Study of Intravenously Administered 23ME-00610 in Patients With Advanced Solid Malignancies","has_exemption":false,"start_date":"2021-12-29","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"23andMe, Inc.","sponsor_slug":"23andme-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04774315","publication_url":"https://clinicaltrials.gov/study/NCT04774315","title":"Molecular Endotypes of Chronic Idiopathic Urticaria","has_exemption":false,"start_date":"2022-01-01","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05107752","publication_url":"https://clinicaltrials.gov/study/NCT05107752","title":"Stellate Ganglion Block to Augment Trauma-focused Therapy Among Veterans With PTSD","has_exemption":false,"start_date":"2022-01-03","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04500834","publication_url":"https://clinicaltrials.gov/study/NCT04500834","title":"Clinical Evaluation of Metal Panel Allergens: Safety and Efficacy Study","has_exemption":false,"start_date":"2022-02-07","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Allerderm","sponsor_slug":"allerderm","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04643418","publication_url":"https://clinicaltrials.gov/study/NCT04643418","title":"Phase 1/2a Dose-ranging, Safety, Pharmacokinetics, and Preliminary Efficacy Study of MPB-1734 in Patients With Advanced Solid Tumors in Part 1 and With Selected Solid Tumors in Part 2","has_exemption":false,"start_date":"2022-03-08","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"MegaPro Biomedical Co. Ltd.","sponsor_slug":"megapro-biomedical-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05479123","publication_url":"https://clinicaltrials.gov/study/NCT05479123","title":"Assessing the Impact of Dosage Frequency of Propranolol on Sleep Patterns in Patients With Infantile Hemangiomas","has_exemption":false,"start_date":"2022-06-23","completion_date":"2025-03-31","has_results":true,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05231213","publication_url":"https://clinicaltrials.gov/study/NCT05231213","title":"Effects of Neuromodulation and Cognitive Training for Suicide in Veterans (ENACTS)","has_exemption":false,"start_date":"2022-07-01","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06469398","publication_url":"https://clinicaltrials.gov/study/NCT06469398","title":"A Post Market Study of a Laser System for the Treatment of Acne Vulgaris","has_exemption":false,"start_date":"2022-07-21","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Cutera Inc.","sponsor_slug":"cutera-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05271292","publication_url":"https://clinicaltrials.gov/study/NCT05271292","title":"A Phase 1b/2, Single-Arm, Open-Label, Dose-Escalation, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Chiauranib for the Treatment of Advanced Solid Tumors and Relapsed/Refractory SCLC","has_exemption":false,"start_date":"2022-08-26","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Chipscreen Biosciences, Ltd.","sponsor_slug":"chipscreen-biosciences-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05304442","publication_url":"https://clinicaltrials.gov/study/NCT05304442","title":"Intravenous Ferric Derisomaltose for Moderate to Severe Anemia Due to Uterine Bleeding in the Emergency Department: a Randomized Trial","has_exemption":false,"start_date":"2022-09-15","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05518123","publication_url":"https://clinicaltrials.gov/study/NCT05518123","title":"A Phase 4, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Tolerability of Rimegepant for the Prevention of Migraine in Adults With a History of Inadequate Response to Oral Preventive Medications","has_exemption":false,"start_date":"2022-11-07","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05283980","publication_url":"https://clinicaltrials.gov/study/NCT05283980","title":"Pectoral Nerve Blocks (PECs) for Cardiovascular Implantable Electronic Device Placement: A Pilot Study","has_exemption":false,"start_date":"2022-11-17","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05724771","publication_url":"https://clinicaltrials.gov/study/NCT05724771","title":"Assessing the Safety and Efficacy of Utilizing CGRPmAb Fremanezumab (Ajovy) in Chronic Migraine Patients Currently on Monotherapy OnabotulinumtoxinA (Botox).","has_exemption":false,"start_date":"2023-01-26","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Chicago Headache Center & Research Institute","sponsor_slug":"chicago-headache-center-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05327062","publication_url":"https://clinicaltrials.gov/study/NCT05327062","title":"CRT-DRIVE: Cardiac Resynchronization Therapy Delivery Guided Non-Invasive Electrical and Venous Anatomy Assessment","has_exemption":false,"start_date":"2023-03-06","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"XSpline S.p.A.","sponsor_slug":"xspline-spa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05463783","publication_url":"https://clinicaltrials.gov/study/NCT05463783","title":"Effect of Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide and Bictegravir/Emtricitabine/Tenofovir Alafenamide on the Circulatory microRNA Profile in Treatment naïve HIV Patients, and Its Correlation With Change in Body Weight","has_exemption":false,"start_date":"2023-03-14","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"East Carolina University","sponsor_slug":"east-carolina-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04902625","publication_url":"https://clinicaltrials.gov/study/NCT04902625","title":"Use of Mysimba in Patients With Weight Regain After Bariatric Surgery","has_exemption":false,"start_date":"2023-03-21","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Zuyderland Medisch Centrum","sponsor_slug":"zuyderland-medisch-centrum","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05069428","publication_url":"https://clinicaltrials.gov/study/NCT05069428","title":"Delirium Reduction With Ramelteon","has_exemption":false,"start_date":"2023-03-26","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Centennial Medical Center","sponsor_slug":"centennial-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06053073","publication_url":"https://clinicaltrials.gov/study/NCT06053073","title":"Induction to Labour With Double Cervical Ballon at Home Versus at Hospital to Improve the Vaginal Delivery Rate, Maternal Satisfaction and Reduce Costs: Multicentric Randomized Clinical Trial","has_exemption":false,"start_date":"2023-03-27","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau","sponsor_slug":"fundacio-institut-de-recerca-de-lhospital-de-la-santa-creu-i-sant-pau","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06359522","publication_url":"https://clinicaltrials.gov/study/NCT06359522","title":"A Comparative Study of Medical Management vs Transcatheter PDA Occlusion Using Near-Infrared Spectroscopy","has_exemption":false,"start_date":"2023-04-18","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Louisville","sponsor_slug":"university-of-louisville","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05700318","publication_url":"https://clinicaltrials.gov/study/NCT05700318","title":"A Pilot Study Assessing Preliminary Safety and Efficacy of The ShiraTronics Migraine Therapy System in Relieving, Interrupting, and Preventing Chronic Migraine","has_exemption":false,"start_date":"2023-05-05","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"ShiraTronics","sponsor_slug":"shiratronics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05978947","publication_url":"https://clinicaltrials.gov/study/NCT05978947","title":"Effect of Sperm Preparation by a Microfluidic Chip Method Versus a Density Gradient Centrifugation Method on Semen Parameters","has_exemption":false,"start_date":"2023-07-01","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Professor Ernest Hung-Yu Ng","sponsor_slug":"professor-ernest-hung-yu-ng","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06434818","publication_url":"https://clinicaltrials.gov/study/NCT06434818","title":"Development and Evaluation of Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders (EDITOR)","has_exemption":false,"start_date":"2023-07-07","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Evon Medics LLC","sponsor_slug":"evon-medics-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06051032","publication_url":"https://clinicaltrials.gov/study/NCT06051032","title":"Prospective Randomized Comparative Study on the Incidence of Pulmonary Emboembolism (PE) After Endovascular Treatment of Thrombosed Dialysis Arterio Venous Fistulas (AVF): Balloon Thrombectomy Versus Thromboaspiration Systems.","has_exemption":false,"start_date":"2023-07-21","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Instituto de Investigacion Sanitaria La Fe","sponsor_slug":"instituto-de-investigacion-sanitaria-la-fe","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06005012","publication_url":"https://clinicaltrials.gov/study/NCT06005012","title":"Semaglutide Treatment in the Real-world for Fibrosis Due to NAFLD in Obesity and T2DM","has_exemption":false,"start_date":"2023-07-25","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05941442","publication_url":"https://clinicaltrials.gov/study/NCT05941442","title":"A Phase 2, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of Darigabat in Participants With Panic Disorder","has_exemption":false,"start_date":"2023-07-31","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05961410","publication_url":"https://clinicaltrials.gov/study/NCT05961410","title":"Eltrombopag Plus G-CSF for Human CD34+ Cell Mobilization in Patients With Lymphoma Undergoing Autologous Stem Cell Harvest","has_exemption":false,"start_date":"2023-08-15","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"National Taiwan University Hospital","sponsor_slug":"national-taiwan-university-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06028984","publication_url":"https://clinicaltrials.gov/study/NCT06028984","title":"Self-guided Treatment for Adolescents/Adults Navigating Depression (STAND-MDD): A Randomized Controlled Trial","has_exemption":false,"start_date":"2023-10-12","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Big Health Inc.","sponsor_slug":"big-health-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06055985","publication_url":"https://clinicaltrials.gov/study/NCT06055985","title":"A Multicenter Phase 2, Double-blind, Placebo-controlled, Randomized, Parallel-group Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of UCB0022 in Study Participants With Advanced Parkinson's Disease","has_exemption":true,"start_date":"2023-11-17","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"UCB Biopharma SRL","sponsor_slug":"ucb-biopharma-srl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06090721","publication_url":"https://clinicaltrials.gov/study/NCT06090721","title":"A PHASE 3 STUDY OF TOLERABILITY, SAFETY, AND EFFICACY, OF DMT310 IN PATIENTS WITH ACNE VULGARIS","has_exemption":false,"start_date":"2023-12-08","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Dermata Therapeutics","sponsor_slug":"dermata-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05859776","publication_url":"https://clinicaltrials.gov/study/NCT05859776","title":"Phase 1/2a Study of the Safety and Bioactivity of AXT107 Injected Suprachoroidally in Subjects With Neovascular Age-Related Macular Degeneration (nAMD)","has_exemption":false,"start_date":"2023-12-19","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"AsclepiX Therapeutics, Inc.","sponsor_slug":"asclepix-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06184230","publication_url":"https://clinicaltrials.gov/study/NCT06184230","title":"Open Label Study to Assess the ~32-Year Persistence of Hepatitis A Antibody Among Participants in the Pivotal, Double-Blind, Placebo-Controlled Efficacy Study of VAQTA (Study 023-001)","has_exemption":false,"start_date":"2024-01-31","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Best Healthcare Inc.","sponsor_slug":"best-healthcare-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06086626","publication_url":"https://clinicaltrials.gov/study/NCT06086626","title":"A Multicenter, Single-arm, Open-label Study to Assess the Pharmacokinetics, Safety, and Tolerability of Cefiderocol in Hospitalized Pediatric Patients From Birth to < 3 Months of Age With Suspected or Confirmed Aerobic Gram-negative Bacterial Infections","has_exemption":true,"start_date":"2024-03-14","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Shionogi","sponsor_slug":"shionogi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06218186","publication_url":"https://clinicaltrials.gov/study/NCT06218186","title":"A Single Arm Quantitative Study Assessing Performance of Wesper Lab as a Tool to Aid in Sleep Apnea Diagnosis in Pediatric Populations","has_exemption":false,"start_date":"2024-03-31","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Wesper Inc","sponsor_slug":"wesper-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06275256","publication_url":"https://clinicaltrials.gov/study/NCT06275256","title":"Outcomes of Minimally Invasive Surgical Treatments (MIST) for Benign Prostatic Hyperplasia (BPH): A Single-Institution Prospective Study","has_exemption":false,"start_date":"2024-03-31","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"University of Manitoba","sponsor_slug":"university-of-manitoba","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06023277","publication_url":"https://clinicaltrials.gov/study/NCT06023277","title":"A Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of ConvitVax in Metastatic Breast Cancer","has_exemption":false,"start_date":"2024-04-01","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Jacinto Convit World Organization Inc.","sponsor_slug":"jacinto-convit-world-organization-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06281249","publication_url":"https://clinicaltrials.gov/study/NCT06281249","title":"Real-time Spine Ultrasound Imaging System: Data Collection Study","has_exemption":false,"start_date":"2024-04-01","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05825924","publication_url":"https://clinicaltrials.gov/study/NCT05825924","title":"Randomized, Two Arm Parallel, Clinical Trial to Compare Effectiveness of Different Tobacco Harm Reduction Products in General Adult Population in Low Middle Income Countries","has_exemption":false,"start_date":"2024-06-30","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Foundation for a Smoke Free World INC","sponsor_slug":"foundation-for-a-smoke-free-world-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06021860","publication_url":"https://clinicaltrials.gov/study/NCT06021860","title":"A Phase IV, Two-part, Open-label Study Assessing the Pharmacokinetics, Safety and Pharmacodynamics of Single and Multiple Doses of Spironolactone Oral Suspension in Pediatric Patients With Edema Due to Heart Failure or Cirrhosis","has_exemption":false,"start_date":"2024-06-30","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"CMP Development, LLC","sponsor_slug":"cmp-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06509191","publication_url":"https://clinicaltrials.gov/study/NCT06509191","title":"Effect of Melatonin Versus Placebo for Prevention of Delirium Among Medically Hospitalized Patients: Study Protocol for a Single-Center, Double-Blinded, Randomised Controlled Trial","has_exemption":false,"start_date":"2024-09-30","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Sultan Qaboos University","sponsor_slug":"sultan-qaboos-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06602284","publication_url":"https://clinicaltrials.gov/study/NCT06602284","title":"A Full Face, Baseline Controlled Study to Evaluate the Efficacy of Dermapen 4™ Microneedling Device in Conjunction with MG-CLR Serum for Acne Treatment Over 12 Weeks.","has_exemption":false,"start_date":"2024-10-31","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Equipmed USA LLC","sponsor_slug":"equipmed-usa-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06710236","publication_url":"https://clinicaltrials.gov/study/NCT06710236","title":"Evaluation of Investigational Hearing Instrument Features","has_exemption":false,"start_date":"2024-11-18","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Sonova AG","sponsor_slug":"sonova-ag","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06713642","publication_url":"https://clinicaltrials.gov/study/NCT06713642","title":"SPOTFIRE ST TITUS STUDY: Provider Identified Target Populations, Implementation, Test Performance, Potential Utility, and Satisfaction of SPOTFIRE ST in the Urgent Care","has_exemption":false,"start_date":"2024-12-02","completion_date":"2025-03-31","has_results":true,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06750627","publication_url":"https://clinicaltrials.gov/study/NCT06750627","title":"Efficacy of Continuous Erector Spinae Plane Block to Reduce Postoperative Pain in Patients Undergoing Unilateral Thoracotomy","has_exemption":false,"start_date":"2025-01-01","completion_date":"2025-03-31","has_results":false,"results_due":false,"sponsor_name":"Udayana University","sponsor_slug":"udayana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02220985","publication_url":"https://clinicaltrials.gov/study/NCT02220985","title":"A Phase II Study Evaluating Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors for Prevention of GVHD","has_exemption":false,"start_date":"2015-02-03","completion_date":"2025-04-01","has_results":false,"results_due":false,"sponsor_name":"Fred Hutchinson Cancer Center","sponsor_slug":"fred-hutchinson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03560466","publication_url":"https://clinicaltrials.gov/study/NCT03560466","title":"One Year Study to Evaluate the Long-term Safety and Tolerability of Dupilumab in Pediatric Patients With Asthma Who Participated in a Previous Dupilumab Asthma Clinical Study","has_exemption":false,"start_date":"2018-06-21","completion_date":"2025-04-01","has_results":true,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03917381","publication_url":"https://clinicaltrials.gov/study/NCT03917381","title":"First-in-human, Open-label, Dose-escalation Trial With Expansion Cohorts to Evaluate Safety of GEN1046 in Subjects With Malignant Solid Tumors","has_exemption":true,"start_date":"2019-05-14","completion_date":"2025-04-01","has_results":false,"results_due":false,"sponsor_name":"Genmab","sponsor_slug":"genmab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04113109","publication_url":"https://clinicaltrials.gov/study/NCT04113109","title":"Mechanisms Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 2","has_exemption":false,"start_date":"2019-11-01","completion_date":"2025-04-01","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04317807","publication_url":"https://clinicaltrials.gov/study/NCT04317807","title":"A 12-week Randomized, Double-blind, Placebo-controlled Trial Investigating the Effects of Levetiracetam in Early Psychosis","has_exemption":true,"start_date":"2020-08-27","completion_date":"2025-04-01","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04455841","publication_url":"https://clinicaltrials.gov/study/NCT04455841","title":"A Phase 1/2 Open-Label, Multicenter Study of INCB000928 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Anemia Due to Myeloproliferative Disorders","has_exemption":false,"start_date":"2021-03-19","completion_date":"2025-04-01","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04922411","publication_url":"https://clinicaltrials.gov/study/NCT04922411","title":"Cortical Network Modulation by Subthalamic Nucleus Deep Brain Stimulation","has_exemption":false,"start_date":"2021-04-23","completion_date":"2025-04-01","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05178043","publication_url":"https://clinicaltrials.gov/study/NCT05178043","title":"A Phase II Study to Evaluate the Efficacy and Safety of GT90001 in Combination With Nivolumab as a Second-line Treatment in Subjects With Advanced Hepatocellular Carcinoma","has_exemption":false,"start_date":"2021-08-01","completion_date":"2025-04-01","has_results":false,"results_due":false,"sponsor_name":"Suzhou Kintor Pharmaceutical Inc,","sponsor_slug":"suzhou-kintor-pharmaceutical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05032326","publication_url":"https://clinicaltrials.gov/study/NCT05032326","title":"Long-term Interventional Follow-up Study up to 4 Years of Age of Children With Prader-Willi Syndrome Included in the OTBB3 Clinical Trial and Comparison With an Untreated Cohort of Children With Prader-Willi Syndrome","has_exemption":false,"start_date":"2021-09-07","completion_date":"2025-04-01","has_results":false,"results_due":false,"sponsor_name":"University Hospital, Toulouse","sponsor_slug":"university-hospital-toulouse","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04939207","publication_url":"https://clinicaltrials.gov/study/NCT04939207","title":"Improving the Cost-effectiveness of Coronary Artery Disease Diagnosis","has_exemption":false,"start_date":"2022-03-22","completion_date":"2025-04-01","has_results":false,"results_due":false,"sponsor_name":"St. Antonius Hospital","sponsor_slug":"st-antonius-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05980585","publication_url":"https://clinicaltrials.gov/study/NCT05980585","title":"Assessment of Heart Failure (HF) At-Home Management Solution ADI Cardio Pulmonary Monitoring System (CPM)","has_exemption":false,"start_date":"2022-04-20","completion_date":"2025-04-01","has_results":false,"results_due":false,"sponsor_name":"Analog Device, Inc.","sponsor_slug":"analog-device-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03999853","publication_url":"https://clinicaltrials.gov/study/NCT03999853","title":"Colonic Delivery of Butyrate to Improve Insulin Sensitivity and Lower Triglycerides in Type 1 Diabetes Subjects","has_exemption":false,"start_date":"2022-07-28","completion_date":"2025-04-01","has_results":true,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05543642","publication_url":"https://clinicaltrials.gov/study/NCT05543642","title":"The COvid19 VaccinE Response and Co-Administration in Rheumatology Patients (COVER-CoAd)","has_exemption":false,"start_date":"2022-10-11","completion_date":"2025-04-01","has_results":false,"results_due":false,"sponsor_name":"Oregon Health and Science University","sponsor_slug":"oregon-health-and-science-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05601128","publication_url":"https://clinicaltrials.gov/study/NCT05601128","title":"An Open-label Study Evaluating the Pharmacokinetics (PK), Efficacy, Safety, and Tolerability of CABENUVA (Long-acting Cabotegravir Plus Long-acting Rilpivirine) Intramuscular (IM) Administered Monthly and Every 2 Months in Virologically Suppressed HIV-1-Infected Adults With Severe Renal Impairment With or Without Hemodialysis (CAPRI)","has_exemption":false,"start_date":"2023-01-01","completion_date":"2025-04-01","has_results":false,"results_due":false,"sponsor_name":"Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)","sponsor_slug":"allegheny-singer-research-institute-also-known-as-allegheny-health-network-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05496322","publication_url":"https://clinicaltrials.gov/study/NCT05496322","title":"Continuous Vs Intermittent Non Invasive Blood Pressure Monitoring in Preventing Post Operative Organ Failure","has_exemption":false,"start_date":"2023-01-26","completion_date":"2025-04-01","has_results":false,"results_due":false,"sponsor_name":"University of Messina","sponsor_slug":"university-of-messina","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05811195","publication_url":"https://clinicaltrials.gov/study/NCT05811195","title":"Comparison of Two Prophylactic Photobiomodulation Protocols in Chemoinduced Oral Mucositis in Pediatric and Adolescent Oncology Patients: a Randomized, Controlled, Blinded Clinical Trial","has_exemption":false,"start_date":"2023-03-10","completion_date":"2025-04-01","has_results":false,"results_due":false,"sponsor_name":"Federal University of Rio Grande do Sul","sponsor_slug":"federal-university-of-rio-grande-do-sul","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05389748","publication_url":"https://clinicaltrials.gov/study/NCT05389748","title":"Phase IIb to Restore Oxygen in Large Vessel Occlusion Patients En Route for MT Using NanO2","has_exemption":false,"start_date":"2023-04-01","completion_date":"2025-04-01","has_results":false,"results_due":false,"sponsor_name":"NuvOx LLC","sponsor_slug":"nuvox-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04510714","publication_url":"https://clinicaltrials.gov/study/NCT04510714","title":"A Prospective, Phase III Study to Assess the Efficacy and Safety of Microwave Ablation of Metastatic Lung Sarcoma Lesions.","has_exemption":false,"start_date":"2023-06-01","completion_date":"2025-04-01","has_results":false,"results_due":false,"sponsor_name":"Instituto do Cancer do Estado de São Paulo","sponsor_slug":"instituto-do-cancer-do-estado-de-sao-paulo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05638802","publication_url":"https://clinicaltrials.gov/study/NCT05638802","title":"A Phase 1b/2, Double-Blind, Placebo-Controlled, Randomized, Parallel-Arm Study to Explore the Safety, Pharmacokinetics, and Proof of Biological Activity of DS-7011a in Patients With Systemic Lupus Erythematosus","has_exemption":false,"start_date":"2023-06-07","completion_date":"2025-04-01","has_results":false,"results_due":false,"sponsor_name":"Daiichi Sankyo","sponsor_slug":"daiichi-sankyo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06116864","publication_url":"https://clinicaltrials.gov/study/NCT06116864","title":"Enhancing Polyp Detection: A Randomized Controlled Trial Comparing Combined Computer-Aid Detection and Polyp-Detecting Colonoscope Attachment to Computer-Aid Detection Alone in Patients Undergoing Colonoscopy.","has_exemption":false,"start_date":"2023-10-23","completion_date":"2025-04-01","has_results":false,"results_due":false,"sponsor_name":"Marshall University","sponsor_slug":"marshall-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05889117","publication_url":"https://clinicaltrials.gov/study/NCT05889117","title":"Neurometabolic Effects of Theta-burst Treatment in Mild Traumatic Brain Injury","has_exemption":false,"start_date":"2023-10-30","completion_date":"2025-04-01","has_results":false,"results_due":false,"sponsor_name":"The Mind Research Network","sponsor_slug":"the-mind-research-network","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05750459","publication_url":"https://clinicaltrials.gov/study/NCT05750459","title":"Exposure-Response Evaluation of IV Artesunate in Children With Severe Malaria","has_exemption":false,"start_date":"2023-11-29","completion_date":"2025-04-01","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06176768","publication_url":"https://clinicaltrials.gov/study/NCT06176768","title":"A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of LY3972406 in Adults With Moderate-to-Severe Plaque Psoriasis","has_exemption":false,"start_date":"2023-12-06","completion_date":"2025-04-01","has_results":true,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06846372","publication_url":"https://clinicaltrials.gov/study/NCT06846372","title":"Effect of 3D Integration of Facial Scanning, Intraoral Scanning and CBCT On Patient Satisfaction and Occlusion of Temporary and Permanent Full Arch Implant Supported Prosthesis","has_exemption":false,"start_date":"2024-03-01","completion_date":"2025-04-01","has_results":false,"results_due":false,"sponsor_name":"Mansoura University","sponsor_slug":"mansoura-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05890027","publication_url":"https://clinicaltrials.gov/study/NCT05890027","title":"Phenylephrine Versus Upper Eyelid Taping For Muller's Muscle Conjunctival Resection Evaluation","has_exemption":false,"start_date":"2024-03-19","completion_date":"2025-04-01","has_results":true,"results_due":false,"sponsor_name":"University of Miami","sponsor_slug":"university-of-miami","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06418022","publication_url":"https://clinicaltrials.gov/study/NCT06418022","title":"Evaluating Fluid Responsiveness in Intensive Care Unit Patients Using VTI and Trendelenburg Positioning. TREND-US Trial.","has_exemption":false,"start_date":"2024-04-01","completion_date":"2025-04-01","has_results":false,"results_due":false,"sponsor_name":"Lenox Hill Hospital","sponsor_slug":"lenox-hill-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06351124","publication_url":"https://clinicaltrials.gov/study/NCT06351124","title":"Feasibility of Beta-hydroxybutyrate Supplementation to Reduce Inflammation in Patients with Inflammatory Bowel Disease","has_exemption":false,"start_date":"2024-08-28","completion_date":"2025-04-01","has_results":false,"results_due":false,"sponsor_name":"University of Texas at Austin","sponsor_slug":"university-of-texas-at-austin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06501963","publication_url":"https://clinicaltrials.gov/study/NCT06501963","title":"Revealing Protective Immunity to Influenza Using Systems Immunology","has_exemption":false,"start_date":"2024-10-14","completion_date":"2025-04-01","has_results":true,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06742554","publication_url":"https://clinicaltrials.gov/study/NCT06742554","title":"Comparative Efficacy of Buprenorphine Transdermal Patch Versus Tramadol in Postoperative Analgesia for Shoulder Arthroscopy: a Randomized Controlled Trial.","has_exemption":false,"start_date":"2024-12-01","completion_date":"2025-04-01","has_results":false,"results_due":false,"sponsor_name":"medina medical center","sponsor_slug":"medina-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06717373","publication_url":"https://clinicaltrials.gov/study/NCT06717373","title":"Point-of-Care Echocardiography in Patients with Known or Suspected Aortic Stenosis","has_exemption":false,"start_date":"2025-02-07","completion_date":"2025-04-01","has_results":false,"results_due":false,"sponsor_name":"Caption Health, Inc.","sponsor_slug":"caption-health-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03212274","publication_url":"https://clinicaltrials.gov/study/NCT03212274","title":"A Phase 2 Study of the PARP Inhibitor Olaparib (AZD2281) in IDH1 and IDH2 Mutant Advanced Solid Tumors","has_exemption":false,"start_date":"2019-01-30","completion_date":"2025-04-02","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04409639","publication_url":"https://clinicaltrials.gov/study/NCT04409639","title":"Phase 2 Trial of Cobimetinib in Newly Diagnosed or HMA-treated CMML Patients With RAS Pathway Mutations","has_exemption":false,"start_date":"2021-01-12","completion_date":"2025-04-02","has_results":false,"results_due":false,"sponsor_name":"University of Utah","sponsor_slug":"university-of-utah","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04611880","publication_url":"https://clinicaltrials.gov/study/NCT04611880","title":"A Trial of Crizanlizumab for the Treatment of Retinal Vasculopathy With Cerebral Leukoencephalopathy (RVCL)","has_exemption":false,"start_date":"2021-01-25","completion_date":"2025-04-02","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04568616","publication_url":"https://clinicaltrials.gov/study/NCT04568616","title":"Phase II Study of Neoadjuvant ArOMatase Inhibitor Therapy for ER+ Breast Cancer (NAOMI)","has_exemption":false,"start_date":"2021-08-13","completion_date":"2025-04-02","has_results":false,"results_due":false,"sponsor_name":"Dartmouth-Hitchcock Medical Center","sponsor_slug":"dartmouth-hitchcock-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04973137","publication_url":"https://clinicaltrials.gov/study/NCT04973137","title":"A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Birtamimab Plus Standard of Care vs. Placebo Plus Standard of Care in Mayo Stage IV Subjects With Light Chain (AL) Amyloidosis","has_exemption":false,"start_date":"2021-08-30","completion_date":"2025-04-02","has_results":true,"results_due":false,"sponsor_name":"Prothena Biosciences Ltd.","sponsor_slug":"prothena-biosciences-ltd","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05089630","publication_url":"https://clinicaltrials.gov/study/NCT05089630","title":"A Phase 1/2, First-Time-in Human (FTiH), Randomized, Observer-blind, Placebo-controlled, Dose Escalation Study to Assess Safety, Reactogenicity and Immunogenicity of a Candidate Cytomegalovirus (CMV) Vaccine Comprising Recombinant Protein and Adjuvant When Administered Intramuscularly in Healthy Adults","has_exemption":false,"start_date":"2021-10-14","completion_date":"2025-04-02","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05169658","publication_url":"https://clinicaltrials.gov/study/NCT05169658","title":"A Pilot Study of Subcutaneous Mosunetuzumab With or Without Polatuzumab Vedotin and Obinutuzumab for Untreated Indolent B-Cell Non-Hodgkin Lymphoma","has_exemption":false,"start_date":"2022-03-23","completion_date":"2025-04-02","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05295459","publication_url":"https://clinicaltrials.gov/study/NCT05295459","title":"ENLIGHTEN 2: A Phase III, Randomized, Blinded, Controlled, Parallel-Group Trial to Evaluate the Efficacy and Safety of LYR-210 for the Treatment of Chronic Rhinosinusitis in Adults","has_exemption":false,"start_date":"2022-05-13","completion_date":"2025-04-02","has_results":true,"results_due":false,"sponsor_name":"Lyra Therapeutics","sponsor_slug":"lyra-therapeutics","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05604170","publication_url":"https://clinicaltrials.gov/study/NCT05604170","title":"A Phase 3, Open-label Study of Adjunctive Ganaxolone (GNX) Treatment in Children and Adults With Tuberous Sclerosis Complex (TSC)-Related Epilepsy (TrustTSC OLE)","has_exemption":false,"start_date":"2022-05-16","completion_date":"2025-04-02","has_results":true,"results_due":false,"sponsor_name":"Marinus Pharmaceuticals","sponsor_slug":"marinus-pharmaceuticals","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05518877","publication_url":"https://clinicaltrials.gov/study/NCT05518877","title":"Low Dose Ketamine Infusion for Analgesia in the Emergency Department (ED) to Reduce Side Effects: A Double Blind, Double Dummy Randomized Controlled Trial","has_exemption":false,"start_date":"2022-12-07","completion_date":"2025-04-02","has_results":true,"results_due":false,"sponsor_name":"Summa Health System","sponsor_slug":"summa-health-system","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06347497","publication_url":"https://clinicaltrials.gov/study/NCT06347497","title":"Safety and Efficacy of Zonisamide Versus Topiramate in Migraine","has_exemption":false,"start_date":"2024-04-01","completion_date":"2025-04-02","has_results":false,"results_due":false,"sponsor_name":"Kafrelsheikh University","sponsor_slug":"kafrelsheikh-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02593175","publication_url":"https://clinicaltrials.gov/study/NCT02593175","title":"Women's Triple-Negative First-Line Study: A Phase II Trial of Panitumumab, Carboplatin and Paclitaxel (PaCT) in Patients With Localized Triple-Negative Breast Cancer (TNBC) With Tumors Predicted Insensitive to Standard Neoadjuvant Chemotherapy","has_exemption":false,"start_date":"2016-11-03","completion_date":"2025-04-03","has_results":true,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT03528694","publication_url":"https://clinicaltrials.gov/study/NCT03528694","title":"A Phase III Randomized, Open-Label, Multi-Center, Global Study of Durvalumab and Bacillus Calmette-Guerin (BCG) Administered as Combination Therapy Versus BCG Alone in High-Risk, BCG Naïve Non-Muscle Invasive Bladder Cancer Patients","has_exemption":true,"start_date":"2018-05-14","completion_date":"2025-04-03","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03196427","publication_url":"https://clinicaltrials.gov/study/NCT03196427","title":"A Phase 2b, Extension Study to Determine the Long-term Safety of Vedolizumab IV in Pediatric Subjects With Ulcerative Colitis or Crohn's Disease","has_exemption":false,"start_date":"2018-07-30","completion_date":"2025-04-03","has_results":true,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03663933","publication_url":"https://clinicaltrials.gov/study/NCT03663933","title":"Phase II Trial of Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation","has_exemption":false,"start_date":"2018-09-04","completion_date":"2025-04-03","has_results":true,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03808558","publication_url":"https://clinicaltrials.gov/study/NCT03808558","title":"A Phase 2 Multi-center Pharmacodynamics Study of TVB-2640 in KRAS Mutant Non-small Cell Lung Carcinomas","has_exemption":false,"start_date":"2019-09-11","completion_date":"2025-04-03","has_results":false,"results_due":false,"sponsor_name":"David E Gerber","sponsor_slug":"david-e-gerber","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04167163","publication_url":"https://clinicaltrials.gov/study/NCT04167163","title":"An Open-Label Phase 2 Study of Abaloparatide to Mitigate Distal Femoral Bone Loss Following Total Knee Arthroplasty","has_exemption":false,"start_date":"2020-01-10","completion_date":"2025-04-03","has_results":false,"results_due":false,"sponsor_name":"University of Wisconsin, Madison","sponsor_slug":"university-of-wisconsin-madison","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05024968","publication_url":"https://clinicaltrials.gov/study/NCT05024968","title":"A Phase 2 Clinical Trial Evaluating the Efficacy and Safety of Sintilimab for Advanced Rare Cancers (SiARa Cancer Study) - Cancer of Unknown Primary (SiARa-CUP)","has_exemption":false,"start_date":"2021-08-26","completion_date":"2025-04-03","has_results":true,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04811092","publication_url":"https://clinicaltrials.gov/study/NCT04811092","title":"A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Sotatercept When Added to Background Pulmonary Arterial Hypertension (PAH) Therapy in Newly Diagnosed Intermediate- and High-risk PAH Patients","has_exemption":false,"start_date":"2022-03-18","completion_date":"2025-04-03","has_results":false,"results_due":false,"sponsor_name":"Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA","sponsor_slug":"acceleron-pharma-inc-a-wholly-owned-subsidiary-of-merck-co-inc-rahway-nj-usa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05189210","publication_url":"https://clinicaltrials.gov/study/NCT05189210","title":"A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Design, Prospective, 52-Week, Phase 2 Clinical Study to Evaluate the Safety and Efficacy of GV1001 Administered Subcutaneously for the Treatment of Mild to Moderate AD","has_exemption":false,"start_date":"2022-10-05","completion_date":"2025-04-03","has_results":false,"results_due":false,"sponsor_name":"GemVax & Kael","sponsor_slug":"gemvax-kael","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05469178","publication_url":"https://clinicaltrials.gov/study/NCT05469178","title":"Phase 1b/2a Safety and Tolerability Study of Bemcentinib With Pembrolizumab/Carboplatin/Pemetrexed in Subjects With Untreated Advanced or Metastatic Non-squamous Non-small Cell Lung Cancer (NSCLC) Without/With a STK11 Mutation","has_exemption":false,"start_date":"2023-03-03","completion_date":"2025-04-03","has_results":true,"results_due":false,"sponsor_name":"BerGenBio ASA","sponsor_slug":"bergenbio-asa","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05761301","publication_url":"https://clinicaltrials.gov/study/NCT05761301","title":"A Phase 1/2, Randomized, Double-blind, Placebo-controlled, 2-Part Study of the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Single Dose ALN-KHK in Overweight to Obese Adult Healthy Volunteers and Multiple Dose ALN-KHK in Obese Patients With Type 2 Diabetes Mellitus (T2DM)","has_exemption":false,"start_date":"2023-03-10","completion_date":"2025-04-03","has_results":false,"results_due":false,"sponsor_name":"Alnylam Pharmaceuticals","sponsor_slug":"alnylam-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06003751","publication_url":"https://clinicaltrials.gov/study/NCT06003751","title":"A Phase 2a Study to Evaluate Safety and Tolerability After Single Administration of PER-001 Intravitreal Implant in Participants With Diabetic Retinopathy","has_exemption":false,"start_date":"2023-08-05","completion_date":"2025-04-03","has_results":false,"results_due":false,"sponsor_name":"Perfuse Therapeutics, Inc.","sponsor_slug":"perfuse-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05971940","publication_url":"https://clinicaltrials.gov/study/NCT05971940","title":"A Phase 3, Randomized, Double-Blind Study to Investigate the Efficacy and Safety of Once Daily Oral LY3502970 Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone","has_exemption":false,"start_date":"2023-08-09","completion_date":"2025-04-03","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05968924","publication_url":"https://clinicaltrials.gov/study/NCT05968924","title":"Improving DFU Outcomes: Early Detection of Foot Ulcers Using Novel Technology","has_exemption":false,"start_date":"2024-07-03","completion_date":"2025-04-03","has_results":false,"results_due":false,"sponsor_name":"Montefiore Medical Center","sponsor_slug":"montefiore-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06542497","publication_url":"https://clinicaltrials.gov/study/NCT06542497","title":"Randomized, Double-masked, Placebo-controlled, Multicenter Study of the Efficacy and Safety of Phentolamine Ophthalmic Solution (POS) 0.75% in Participants With Presbyopia","has_exemption":false,"start_date":"2024-08-15","completion_date":"2025-04-03","has_results":false,"results_due":false,"sponsor_name":"Ocuphire Pharma, Inc.","sponsor_slug":"ocuphire-pharma-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06587217","publication_url":"https://clinicaltrials.gov/study/NCT06587217","title":"Neurobiological Drivers of Mobility Resilience: The Dopaminergic System","has_exemption":false,"start_date":"2024-10-29","completion_date":"2025-04-03","has_results":true,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04093323","publication_url":"https://clinicaltrials.gov/study/NCT04093323","title":"A Phase II Study of Type-1 Polarized Dendritic Cell (aDC1) -Based Treatment in Combination With Tumor-Selective Chemokine Modulation (CKM: Interferon Alpha 2b, Rintatolimod and Celecoxib) in Melanoma Patients With Primary PD-1/PD-L1 Resistance","has_exemption":false,"start_date":"2024-11-13","completion_date":"2025-04-03","has_results":true,"results_due":false,"sponsor_name":"Roswell Park Cancer Institute","sponsor_slug":"roswell-park-cancer-institute","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04552990","publication_url":"https://clinicaltrials.gov/study/NCT04552990","title":"Jet-Injection Assisted Photodynamic Therapy for Basal Cell Carcinoma","has_exemption":false,"start_date":"2020-09-09","completion_date":"2025-04-04","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04645355","publication_url":"https://clinicaltrials.gov/study/NCT04645355","title":"Immunogenetic Profiling of Guselkumab for the Treatment of Plaque and Guttate Psoriasis","has_exemption":false,"start_date":"2021-03-01","completion_date":"2025-04-04","has_results":false,"results_due":false,"sponsor_name":"University of California, San Francisco","sponsor_slug":"university-of-california-san-francisco","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05053503","publication_url":"https://clinicaltrials.gov/study/NCT05053503","title":"Delivering Transcutaneous Auricular Neurostimulation to Improve Relapse Prevention in Opioid Use Disorder","has_exemption":false,"start_date":"2022-05-27","completion_date":"2025-04-04","has_results":false,"results_due":false,"sponsor_name":"Spark Biomedical, Inc.","sponsor_slug":"spark-biomedical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05384860","publication_url":"https://clinicaltrials.gov/study/NCT05384860","title":"Incorporating Acupuncture Into ERAS for Ambulatory Total Hip Replacement (THR) Surgery","has_exemption":false,"start_date":"2022-07-06","completion_date":"2025-04-04","has_results":false,"results_due":false,"sponsor_name":"Hospital for Special Surgery, New York","sponsor_slug":"hospital-for-special-surgery-new-york","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05147571","publication_url":"https://clinicaltrials.gov/study/NCT05147571","title":"RNS® System Responsive Thalamic Stimulation for Primary Generalized Seizures (NAUTILUS) Study","has_exemption":false,"start_date":"2022-08-09","completion_date":"2025-04-04","has_results":false,"results_due":false,"sponsor_name":"NeuroPace","sponsor_slug":"neuropace","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05822245","publication_url":"https://clinicaltrials.gov/study/NCT05822245","title":"A Phase 1/2a Study to Evaluate Safety, Tolerability, and Pharmacodynamic Effect After Single Administration of PER-001 Intravitreal Implant in Participants With Open-Angle Glaucoma","has_exemption":false,"start_date":"2023-05-25","completion_date":"2025-04-04","has_results":false,"results_due":false,"sponsor_name":"Perfuse Therapeutics, Inc.","sponsor_slug":"perfuse-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05972720","publication_url":"https://clinicaltrials.gov/study/NCT05972720","title":"An Open-label, Multicenter Phase 2 Study Evaluating the Efficacy and Safety of Firi-cel, a CD22-directed Autologous Chimeric Antigen Receptor (CAR) T-cell Therapy in Patients With Relapsed/Refractory Large B-Cell Lymphoma After CD19-directed CAR T-cell Therapy","has_exemption":false,"start_date":"2023-08-01","completion_date":"2025-04-04","has_results":false,"results_due":false,"sponsor_name":"CARGO Therapeutics","sponsor_slug":"cargo-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06097260","publication_url":"https://clinicaltrials.gov/study/NCT06097260","title":"A Randomized, Double-blind, Dose-ranging, Placebo-controlled Study to Evaluate the Efficacy and Safety of Bexotegrast (PLN-74809) for the Treatment of Idiopathic Pulmonary Fibrosis (BEACON-IPF)","has_exemption":false,"start_date":"2023-11-16","completion_date":"2025-04-04","has_results":false,"results_due":false,"sponsor_name":"Pliant Therapeutics, Inc.","sponsor_slug":"pliant-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06556173","publication_url":"https://clinicaltrials.gov/study/NCT06556173","title":"A Phase 2a, Single Site, Open-Label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of VTX3232 in Participants With Early-Stage Parkinson's Disease","has_exemption":true,"start_date":"2024-08-08","completion_date":"2025-04-04","has_results":false,"results_due":false,"sponsor_name":"Zomagen Biosciences, Ltd","sponsor_slug":"zomagen-biosciences-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05554354","publication_url":"https://clinicaltrials.gov/study/NCT05554354","title":"Phase 2 Trial of Fulvestrant and Binimetinib in Patients With Hormone Receptor-Positive Metastatic Breast Cancer With Inactivating or Inferred Inactivating NF1 Alterations: A ComboMATCH Treatment Trial","has_exemption":false,"start_date":"2024-09-13","completion_date":"2025-04-04","has_results":true,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06507566","publication_url":"https://clinicaltrials.gov/study/NCT06507566","title":"Phase 1 Study Evaluating Technologies for Point-of-Care Blood Collections in Support of Decentralized Outpatient Assessments in Pandemic and Clinical Trial Settings","has_exemption":false,"start_date":"2024-10-29","completion_date":"2025-04-04","has_results":true,"results_due":false,"sponsor_name":"Alachua Government Services, Inc.","sponsor_slug":"alachua-government-services-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06609616","publication_url":"https://clinicaltrials.gov/study/NCT06609616","title":"Feasibility Of Measuring Volume of Inspiration Via Non-Invasive Motion Sensors","has_exemption":false,"start_date":"2025-01-21","completion_date":"2025-04-04","has_results":true,"results_due":false,"sponsor_name":"National Institutes of Health Clinical Center (CC)","sponsor_slug":"national-institutes-of-health-clinical-center-cc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03141671","publication_url":"https://clinicaltrials.gov/study/NCT03141671","title":"Randomized Phase II Study of Salvage XRT + ADT +/- Abiraterone Acetate and Apalutamide (ARN-509) for Rising PSA After Radical Prostatectomy With Adverse Features.(FORMULA-509 Trial)","has_exemption":false,"start_date":"2017-11-24","completion_date":"2025-04-05","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04525755","publication_url":"https://clinicaltrials.gov/study/NCT04525755","title":"A Translational Randomized Clinical Trial of Varenicline Sampling to Promote Smoking Cessation and Scalable Treatment Dissemination","has_exemption":false,"start_date":"2021-02-08","completion_date":"2025-04-05","has_results":true,"results_due":false,"sponsor_name":"Medical University of South Carolina","sponsor_slug":"medical-university-of-south-carolina","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05208242","publication_url":"https://clinicaltrials.gov/study/NCT05208242","title":"Small Volume Fluid Resuscitation and Supplementation With 20% albumIn Versus Buffered Crystalloids in PatiEnts With Septic Shock","has_exemption":false,"start_date":"2023-11-10","completion_date":"2025-04-05","has_results":false,"results_due":false,"sponsor_name":"Manchester University NHS Foundation Trust","sponsor_slug":"manchester-university-nhs-foundation-trust","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06694610","publication_url":"https://clinicaltrials.gov/study/NCT06694610","title":"A Study on the Relationship Between Individualized Low Voltage Regions in Left Atrium and the Mechanism of Atrial Fibrillation in Persistent Atrial Fibrillation Under Ultra-High-Resolution Mapping","has_exemption":false,"start_date":"2024-11-15","completion_date":"2025-04-05","has_results":false,"results_due":false,"sponsor_name":"The Third People's Hospital of Chengdu","sponsor_slug":"the-third-peoples-hospital-of-chengdu","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03997786","publication_url":"https://clinicaltrials.gov/study/NCT03997786","title":"A Multicenter, Randomized, Placebo and Active Comparator-controlled Clinical Trial to Study the Efficacy, Safety and Pharmacokinetics (PK) of Tildrakizumab in Pediatric Subjects From 6 to <18 Years of Age With Moderate to Severe Chronic Plaque Psoriasis","has_exemption":true,"start_date":"2020-01-15","completion_date":"2025-04-07","has_results":false,"results_due":false,"sponsor_name":"Sun Pharmaceutical Industries Limited","sponsor_slug":"sun-pharmaceutical-industries-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05436535","publication_url":"https://clinicaltrials.gov/study/NCT05436535","title":"Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis (ADRN-12)","has_exemption":false,"start_date":"2022-11-21","completion_date":"2025-04-07","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05952869","publication_url":"https://clinicaltrials.gov/study/NCT05952869","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-0616 in Adults With Heterozygous Familial Hypercholesterolemia.","has_exemption":false,"start_date":"2023-08-08","completion_date":"2025-04-07","has_results":true,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06834568","publication_url":"https://clinicaltrials.gov/study/NCT06834568","title":"Tandem Freedom - Feasibility Trial 2","has_exemption":false,"start_date":"2025-03-24","completion_date":"2025-04-07","has_results":true,"results_due":false,"sponsor_name":"Tandem Diabetes Care, Inc.","sponsor_slug":"tandem-diabetes-care-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT02632175","publication_url":"https://clinicaltrials.gov/study/NCT02632175","title":"A Multi-Center, Open-Label Study of the Human Anti-TNF Monoclonal Antibody Adalimumab to Evaluate Long-Term Safety and Tolerability of Repeated Administration of Adalimumab in Pediatric Subjects With Ulcerative Colitis Who Completed the Study M11-290","has_exemption":false,"start_date":"2015-11-26","completion_date":"2025-04-08","has_results":true,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT04120805","publication_url":"https://clinicaltrials.gov/study/NCT04120805","title":"Randomized, Prospective Evaluation of Hemostatic Agents in Robotic-Assisted Laparoscopic Partial Nephrectomy","has_exemption":false,"start_date":"2016-01-01","completion_date":"2025-04-08","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03846492","publication_url":"https://clinicaltrials.gov/study/NCT03846492","title":"Targeting Brain Physiology to Treat Neuropsychiatric Symptoms of Dementia Using TMS-EEG and tDCS","has_exemption":false,"start_date":"2019-04-24","completion_date":"2025-04-08","has_results":false,"results_due":false,"sponsor_name":"Centre for Addiction and Mental Health","sponsor_slug":"centre-for-addiction-and-mental-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04254549","publication_url":"https://clinicaltrials.gov/study/NCT04254549","title":"Evaluating the Therapeutic Efficacy of Rifaximin in Patients With Diabetic Gastroparesis Using Bloating as the Primary Endpoint.","has_exemption":false,"start_date":"2019-06-14","completion_date":"2025-04-08","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04555837","publication_url":"https://clinicaltrials.gov/study/NCT04555837","title":"A Phase I-II, Open Label Study Evaluating the Safety and Efficacy of Alisertib and Pembrolizumab in Patients With Rb-Deficient Head and Neck Squamous Cell Carcinomas","has_exemption":false,"start_date":"2020-09-15","completion_date":"2025-04-08","has_results":true,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04512235","publication_url":"https://clinicaltrials.gov/study/NCT04512235","title":"A Phase 3, Double-Blind, Multicenter Study to Evaluate the Efficacy and Safety of CAEL-101 and Plasma Cell Dyscrasia Treatment Versus Placebo and Plasma Cell Dyscrasia Treatment in Plasma Cell Dyscrasia Treatment Naïve Patients With Mayo Stage IIIa AL Amyloidosis","has_exemption":false,"start_date":"2020-11-03","completion_date":"2025-04-08","has_results":false,"results_due":false,"sponsor_name":"Alexion Pharmaceuticals, Inc.","sponsor_slug":"alexion-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04504812","publication_url":"https://clinicaltrials.gov/study/NCT04504812","title":"A Sequenced Strategy for Improving Outcomes in People With Knee Osteoarthritis Pain","has_exemption":true,"start_date":"2021-02-01","completion_date":"2025-04-08","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05159388","publication_url":"https://clinicaltrials.gov/study/NCT05159388","title":"A First in Human Phase 1-2 Open-Label, Multicenter, Dose Escalation and Expansion Study of PRS-344/S095012 in Patients With Solid Tumors","has_exemption":false,"start_date":"2021-09-08","completion_date":"2025-04-08","has_results":false,"results_due":false,"sponsor_name":"Servier Bio-Innovation LLC","sponsor_slug":"servier-bio-innovation-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06949358","publication_url":"https://clinicaltrials.gov/study/NCT06949358","title":"A Long-Term Follow-up Study to Evaluate Safety and Tolerability of Olipudase Alfa in Patients Who Completed the DFI12712 or the LTS13632 Study in France","has_exemption":false,"start_date":"2021-11-18","completion_date":"2025-04-08","has_results":true,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05226689","publication_url":"https://clinicaltrials.gov/study/NCT05226689","title":"A Prospective, Multicenter, RSA Study of the Porous Tibia Baseplate W/Jrny Lock","has_exemption":false,"start_date":"2022-04-11","completion_date":"2025-04-08","has_results":false,"results_due":false,"sponsor_name":"Canadian Radiostereometric Analysis Network","sponsor_slug":"canadian-radiostereometric-analysis-network","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05756166","publication_url":"https://clinicaltrials.gov/study/NCT05756166","title":"Phase I/IIa Clinical Trial Evaluating the Safety and Efficacy of Rintatolimod Combined With IFNα2b (Bioferon®) to Enhance the Effectiveness of Pembrolizumab in Patients With Metastatic Triple Negative Breast Cancer","has_exemption":false,"start_date":"2024-02-16","completion_date":"2025-04-08","has_results":false,"results_due":false,"sponsor_name":"Roswell Park Cancer Institute","sponsor_slug":"roswell-park-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06514742","publication_url":"https://clinicaltrials.gov/study/NCT06514742","title":"A Randomized, Double-blind, Multicenter, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy and an Open Label Long-term Extension Treatment With Aticaprant","has_exemption":false,"start_date":"2024-06-26","completion_date":"2025-04-08","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04699630","publication_url":"https://clinicaltrials.gov/study/NCT04699630","title":"A Phase II Study of U3-1402 (Patritumab Deruxtecan) in Patients With Metastatic Breast Cancer","has_exemption":false,"start_date":"2021-05-03","completion_date":"2025-04-09","has_results":false,"results_due":false,"sponsor_name":"SCRI Development Innovations, LLC","sponsor_slug":"scri-development-innovations-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05232851","publication_url":"https://clinicaltrials.gov/study/NCT05232851","title":"Stimulating Immune Response With Neoadjuvant Human Papilloma Virus (HPV)-16 Specific Vaccination in HPV-Oropharyngeal Squamous Cell Carcinoma (HPV-OPSCC)","has_exemption":false,"start_date":"2022-06-16","completion_date":"2025-04-09","has_results":true,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05686239","publication_url":"https://clinicaltrials.gov/study/NCT05686239","title":"An Adaptive, Randomized, Placebo-controlled, Double-blind Study to Evaluate the Safety and Efficacy of RL-007 in the Treatment of Cognitive Impairment Associated With Schizophrenia (CIAS)","has_exemption":false,"start_date":"2022-12-08","completion_date":"2025-04-09","has_results":false,"results_due":false,"sponsor_name":"Recognify Life Sciences","sponsor_slug":"recognify-life-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05660772","publication_url":"https://clinicaltrials.gov/study/NCT05660772","title":"A Randomized, Multi-center, Double Blind, Parallel Study to Examine the Effect of Lipogems Processed Microfragmented Adipose Tissue in Comparison to Corticosteroid for the Treatment of Knee Osteoarthritis","has_exemption":false,"start_date":"2022-12-30","completion_date":"2025-04-09","has_results":false,"results_due":false,"sponsor_name":"Lipogems International spa","sponsor_slug":"lipogems-international-spa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06099782","publication_url":"https://clinicaltrials.gov/study/NCT06099782","title":"A Phase 2 Study to Evaluate Patient Reported Preference for Subcutaneous Pembrolizumab Coformulated With Hyaluronidase (MK-3475A) Over Intravenous Pembrolizumab Formulation in Participants With Multiple Tumor Types (MK-3475A-F11)","has_exemption":false,"start_date":"2023-12-26","completion_date":"2025-04-09","has_results":true,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06429722","publication_url":"https://clinicaltrials.gov/study/NCT06429722","title":"A Phase 2a, Randomized, Double-blind, Placebo-controlled Pilot Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With a Major Depressive Episode Associated With Bipolar II Disorder","has_exemption":true,"start_date":"2024-05-13","completion_date":"2025-04-09","has_results":false,"results_due":false,"sponsor_name":"Neumora Therapeutics, Inc.","sponsor_slug":"neumora-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06635135","publication_url":"https://clinicaltrials.gov/study/NCT06635135","title":"A Randomized, Double-blind, Multicenter, Placebo-controlled Study of Adjunctive Aticaprant Plus an Antidepressant for Relapse Prevention in Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia","has_exemption":false,"start_date":"2024-09-19","completion_date":"2025-04-09","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04046224","publication_url":"https://clinicaltrials.gov/study/NCT04046224","title":"A Phase I/II, Multicenter, Open-Label, Single-Dose, Dose-Ranging Study to Assess the Safety and Tolerability of ST-920, an AAV2/6 Human Alpha Galactosidase A Gene Therapy, in Subjects With Fabry Disease (STAAR)","has_exemption":false,"start_date":"2019-07-23","completion_date":"2025-04-10","has_results":true,"results_due":false,"sponsor_name":"Sangamo Therapeutics","sponsor_slug":"sangamo-therapeutics","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04567537","publication_url":"https://clinicaltrials.gov/study/NCT04567537","title":"Ablative Fractional Laser Treatment for the Improvement of Hypertrophic Scars and Scleroderma: a Prospective Cohort Study","has_exemption":false,"start_date":"2021-06-02","completion_date":"2025-04-10","has_results":true,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04269213","publication_url":"https://clinicaltrials.gov/study/NCT04269213","title":"A Phase II Study of CPX-351 in Younger Patients &lt; 60 Years Old With Secondary Acute Myeloid Leukemia","has_exemption":false,"start_date":"2021-07-29","completion_date":"2025-04-10","has_results":false,"results_due":false,"sponsor_name":"Roswell Park Cancer Institute","sponsor_slug":"roswell-park-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05177211","publication_url":"https://clinicaltrials.gov/study/NCT05177211","title":"A Phase 2 Study of Fedratinib in Myelodysplastic /Myeloproliferative Neoplasms (MDS/MPNs) and Chronic Neutrophilic Leukemia (CNL)","has_exemption":false,"start_date":"2022-03-01","completion_date":"2025-04-10","has_results":true,"results_due":false,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05536297","publication_url":"https://clinicaltrials.gov/study/NCT05536297","title":"An Open-label Extension (OLE) Phase 3 Trial to Assess the Safety of Intravitreal Administration of Avacincaptad Pegol (Complement C5 Inhibitor) in Patients With Geographic Atrophy Who Previously Completed Phase 3 Study ISEE2008 (GATHER2)","has_exemption":false,"start_date":"2022-09-26","completion_date":"2025-04-10","has_results":true,"results_due":false,"sponsor_name":"Astellas Pharma Global Development, Inc.","sponsor_slug":"astellas-pharma-global-development-inc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05453578","publication_url":"https://clinicaltrials.gov/study/NCT05453578","title":"A Phase 1b/2, Multi-Centered, Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Microbiological Activity of a Single Dose of Bacteriophage Therapy in Cystic Fibrosis Subjects Colonized With Pseudomonas Aeruginosa","has_exemption":false,"start_date":"2022-10-03","completion_date":"2025-04-10","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06101134","publication_url":"https://clinicaltrials.gov/study/NCT06101134","title":"A Phase 2 Open-label, Two-cohort Study to Evaluate Patient Preference for Nivolumab + Relatlimab Fixed-dose Combination Subcutaneous Versus Nivolumab + Relatlimab Fixed-dose Combination Intravenous and Nivolumab Subcutaneous Versus Nivolumab Intravenous in Participants With Melanoma","has_exemption":false,"start_date":"2023-11-06","completion_date":"2025-04-10","has_results":true,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05730712","publication_url":"https://clinicaltrials.gov/study/NCT05730712","title":"Phase II Trial of Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf (HP) Plus Enzalutamide for the Treatment of Selected Patients With Metastatic Castration-Resistant Prostate Cancer (TraPPer)","has_exemption":false,"start_date":"2024-03-08","completion_date":"2025-04-10","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06326060","publication_url":"https://clinicaltrials.gov/study/NCT06326060","title":"Investigation of the Safety and Efficacy of Once Weekly NNC0519-0130 in Participants With Overweight or Obesity - a Dose Finding Study","has_exemption":true,"start_date":"2024-03-18","completion_date":"2025-04-10","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04029480","publication_url":"https://clinicaltrials.gov/study/NCT04029480","title":"A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled Clinical Study to Evaluate the Safety and Efficacy of Ertugliflozin (MK-8835/PF-04971729) in Pediatric Participants (Ages 10 to 17 Years, Inclusive) With Type 2 Diabetes Mellitus","has_exemption":false,"start_date":"2019-10-08","completion_date":"2025-04-11","has_results":true,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04459052","publication_url":"https://clinicaltrials.gov/study/NCT04459052","title":"Phase II: Physiological Effects of Nutritional Support in Patients With Parkinson's Disease","has_exemption":false,"start_date":"2020-04-30","completion_date":"2025-04-11","has_results":false,"results_due":false,"sponsor_name":"Thomas Jefferson University","sponsor_slug":"thomas-jefferson-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04630808","publication_url":"https://clinicaltrials.gov/study/NCT04630808","title":"A Phase 3, Randomized, Multi-Regional, Double-Masked, Parallel-Group Trial Evaluating the Safety and Efficacy of NCX 470 0.1% vs. Latanoprost 0.005% in Subjects With Open-Angle Glaucoma or Ocular Hypertension (Denali)","has_exemption":true,"start_date":"2020-11-09","completion_date":"2025-04-11","has_results":false,"results_due":false,"sponsor_name":"Nicox Ophthalmics, Inc.","sponsor_slug":"nicox-ophthalmics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04701983","publication_url":"https://clinicaltrials.gov/study/NCT04701983","title":"Randomized, Double-blind, Placebo-controlled, Parallel Group Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD)","has_exemption":true,"start_date":"2020-12-16","completion_date":"2025-04-11","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04929678","publication_url":"https://clinicaltrials.gov/study/NCT04929678","title":"A Prospective, Multi-Center Study of the Braive™ Growth Modulation System When Used in the Treatment of Pediatric Patients Diagnosed With Juvenile or Adolescent Idiopathic Scoliosis","has_exemption":false,"start_date":"2021-08-12","completion_date":"2025-04-11","has_results":true,"results_due":false,"sponsor_name":"Medtronic Spinal and Biologics","sponsor_slug":"medtronic-spinal-and-biologics","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04930094","publication_url":"https://clinicaltrials.gov/study/NCT04930094","title":"A Randomized, Parallel-group, Double-blind, Placebo-controlled, Multicenter Phase III Trial to Investigate the Efficacy and Safety of Secukinumab 300 mg and 150 mg Administered Subcutaneously Versus Placebo, in Combination With a Glucocorticoid Taper Regimen, in Patients With Giant Cell Arteritis (GCA) (GCAptAIN)","has_exemption":true,"start_date":"2021-10-06","completion_date":"2025-04-11","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05906914","publication_url":"https://clinicaltrials.gov/study/NCT05906914","title":"A Monocenter Prospective Single Arm Study of Cladribine Plus Homoharringtonine and Cytarabine Regimen (CHA) for Induced Therapy in Adults de Novo Acute Myeloid Leukemia (Non-M3)","has_exemption":false,"start_date":"2022-10-26","completion_date":"2025-04-11","has_results":false,"results_due":false,"sponsor_name":"First Affiliated Hospital of Zhejiang University","sponsor_slug":"first-affiliated-hospital-of-zhejiang-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06224192","publication_url":"https://clinicaltrials.gov/study/NCT06224192","title":"A Phase 3, Multicenter, Randomized, Open-label, Performance Study With Self-administered Subcutaneous Rocatinlimab (AMG 451) in Adolescent and Adult Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Outpost)","has_exemption":true,"start_date":"2024-04-02","completion_date":"2025-04-11","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06282458","publication_url":"https://clinicaltrials.gov/study/NCT06282458","title":"A Phase 2 Dose-Finding and Proof-of-Concept Study to Evaluate the Effect on Body Composition and Safety of Enobosarm in Patients Treated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Chronic Weight Management","has_exemption":false,"start_date":"2024-04-29","completion_date":"2025-04-11","has_results":false,"results_due":false,"sponsor_name":"Veru Inc.","sponsor_slug":"veru-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06241573","publication_url":"https://clinicaltrials.gov/study/NCT06241573","title":"Lunsayil LTE: An Extension Trial Assessing Long-term Spesolimab Treatment in Patients With Hidradenitis Suppurativa (HS)","has_exemption":false,"start_date":"2024-05-08","completion_date":"2025-04-11","has_results":false,"results_due":false,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05815498","publication_url":"https://clinicaltrials.gov/study/NCT05815498","title":"A Randomized, Observer-Blind, Active-Controlled Phase 3 Study to Investigate the Safety, Immunogenicity, and Relative Vaccine Efficacy of mRNA-1283 Compared With mRNA-1273 in Participants Aged ≥12 Years for the Prevention of COVID-19","has_exemption":false,"start_date":"2023-03-28","completion_date":"2025-04-12","has_results":false,"results_due":false,"sponsor_name":"ModernaTX, Inc.","sponsor_slug":"modernatx-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06396065","publication_url":"https://clinicaltrials.gov/study/NCT06396065","title":"A Randomized, Double-blind, Multi-center, Phase III Study of AK112 or Placebo Combined With Pemetrexed and Carboplatin in Patients With EGFR-mutant Locally Advanced or Metastatic Non-squamous NSCLC Who Have Failed to EGFR-TKI Treatment","has_exemption":true,"start_date":"2023-05-04","completion_date":"2025-04-12","has_results":false,"results_due":false,"sponsor_name":"Summit Therapeutics","sponsor_slug":"summit-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02494258","publication_url":"https://clinicaltrials.gov/study/NCT02494258","title":"A Phase 2, Open-Label, Single-Arm Rollover Study to Evaluate Long-Term Safety in Subjects Who Participated in Other Celgene Sponsored CC-486 (Oral Azacitidine) Clinical Trials in Hematological Disorders","has_exemption":false,"start_date":"2015-10-22","completion_date":"2025-04-14","has_results":true,"results_due":false,"sponsor_name":"Celgene","sponsor_slug":"celgene","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02632448","publication_url":"https://clinicaltrials.gov/study/NCT02632448","title":"A Phase 1b/2a Three-Part Open-Label Multicenter Study to Evaluate the Safety and Efficacy of LY2880070 as Monotherapy and in Combination With Gemcitabine in Patients With Advanced or Metastatic Cancer","has_exemption":false,"start_date":"2016-05-16","completion_date":"2025-04-14","has_results":false,"results_due":false,"sponsor_name":"Esperas Pharma Inc.","sponsor_slug":"esperas-pharma-inc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03573024","publication_url":"https://clinicaltrials.gov/study/NCT03573024","title":"Safety and Efficacy of Venetoclax and Azacitidine for Newly Diagnosed Non-Elderly Adult Patients (Aged 18-59) With Acute Myeloid Leukemia","has_exemption":false,"start_date":"2018-11-28","completion_date":"2025-04-14","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03702920","publication_url":"https://clinicaltrials.gov/study/NCT03702920","title":"Effects of Plasma Exchange With Human Serum Albumin 5% (PE-A 5%) on Short-term Survival in Subjects With \"Acute-On-Chronic Liver Failure\" (ACLF) at High Risk of Hospital Mortality","has_exemption":false,"start_date":"2019-02-21","completion_date":"2025-04-14","has_results":false,"results_due":false,"sponsor_name":"Grifols Therapeutics LLC","sponsor_slug":"grifols-therapeutics-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04021043","publication_url":"https://clinicaltrials.gov/study/NCT04021043","title":"Phase I/II Trial of Ipilimumab or Nivolumab With BMS-986156 and Hypofractionated Stereotactic Radiation Therapy in Patients With Advanced Solid Malignancies","has_exemption":false,"start_date":"2019-08-19","completion_date":"2025-04-14","has_results":true,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04411199","publication_url":"https://clinicaltrials.gov/study/NCT04411199","title":"D-PLEX 312 - Phase III, Prospective, Multinational, Multicenter, Randomized, Controlled, Two-arm, Double Blind Study to Assess Efficacy and Safety of D-PLEX In Prevention of Post Abdominal Surgery Incisional Infection (SHIELD II)","has_exemption":false,"start_date":"2020-12-15","completion_date":"2025-04-14","has_results":false,"results_due":false,"sponsor_name":"PolyPid Ltd.","sponsor_slug":"polypid-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05153772","publication_url":"https://clinicaltrials.gov/study/NCT05153772","title":"A Phase 2 Open Label Study to Evaluate the Safety and Effectiveness of 212Pb-DOTAMTATE in Subjects With Somatostatin Receptor Expressing Neuroendocrine Tumors","has_exemption":true,"start_date":"2021-12-21","completion_date":"2025-04-14","has_results":false,"results_due":false,"sponsor_name":"Orano Med LLC","sponsor_slug":"orano-med-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06039189","publication_url":"https://clinicaltrials.gov/study/NCT06039189","title":"A Phase 3b, Multicenter, Randomized, Double-blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Guselkumab Versus Placebo for the Treatment of Low Body Surface Area (BSA) Moderate Plaque Psoriasis With Special Site Involvement","has_exemption":false,"start_date":"2023-08-24","completion_date":"2025-04-14","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05992103","publication_url":"https://clinicaltrials.gov/study/NCT05992103","title":"Single-Stage Gastric Fundus Ablation and Endoscopic Sleeve Gastroplasty for Weight Loss","has_exemption":false,"start_date":"2023-09-14","completion_date":"2025-04-14","has_results":false,"results_due":false,"sponsor_name":"True You Weight Loss","sponsor_slug":"true-you-weight-loss","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05813912","publication_url":"https://clinicaltrials.gov/study/NCT05813912","title":"Protocol Title: A Single Arm Study Investigating the Glycaemic Control and Safety of Adding Semaglutide to Insulin Icodec in Participants With Type 2 Diabetes Qualifying for Treatment Intensification Short Title: A Research Study to See How a New Weekly Insulin, Insulin Icodec When Given Along With Semaglutide Helps in Reducing the Blood Sugar Level in Patients With Type 2 Diabetes","has_exemption":false,"start_date":"2023-09-22","completion_date":"2025-04-14","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05998018","publication_url":"https://clinicaltrials.gov/study/NCT05998018","title":"Randomized Study of the pdSTIM™ System (Phrenic Nerve to Diaphragm STIMulation) in Failure to Wean Mechanically Ventilated Patients","has_exemption":false,"start_date":"2023-09-29","completion_date":"2025-04-14","has_results":false,"results_due":false,"sponsor_name":"Stimdia Medical, Inc.","sponsor_slug":"stimdia-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06391593","publication_url":"https://clinicaltrials.gov/study/NCT06391593","title":"Double-Blind, Single and Multiple Dose Study to Determine Pharmacodynamic Markers, Pharmacokinetic Parameters, and Safety of ALTO-203 in Patients With Major Depressive Disorder","has_exemption":true,"start_date":"2024-03-25","completion_date":"2025-04-14","has_results":false,"results_due":false,"sponsor_name":"Alto Neuroscience","sponsor_slug":"alto-neuroscience","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03679676","publication_url":"https://clinicaltrials.gov/study/NCT03679676","title":"Phase 2 Randomized Controlled Trial Using Biologics to Improve Multi OIT Outcomes","has_exemption":false,"start_date":"2020-02-05","completion_date":"2025-04-15","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04099680","publication_url":"https://clinicaltrials.gov/study/NCT04099680","title":"Free Gingival Grafts (FGGs) in Mandibular Posterior Sites: A Randomized Clinical Trials of Wound Healing Following Different Recipient Bed Preparations","has_exemption":false,"start_date":"2020-12-31","completion_date":"2025-04-15","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04586699","publication_url":"https://clinicaltrials.gov/study/NCT04586699","title":"Meditation Accelerated Brain Stimulation for Depression","has_exemption":false,"start_date":"2021-07-15","completion_date":"2025-04-15","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05001984","publication_url":"https://clinicaltrials.gov/study/NCT05001984","title":"Trial of PCSK9 Inhibition in Patients with Acute Stroke and Symptomatic Intracranial Atherosclerosis - a Prospective, Randomized, Open-label, Blinded End-point Study with High-resolution MR Vessel Wall Imaging","has_exemption":false,"start_date":"2021-08-01","completion_date":"2025-04-15","has_results":false,"results_due":false,"sponsor_name":"Chang Gung Memorial Hospital","sponsor_slug":"chang-gung-memorial-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05756803","publication_url":"https://clinicaltrials.gov/study/NCT05756803","title":"Changes in Penile Firmness With Low-Intensity Shockwave Therapy (LiST)","has_exemption":false,"start_date":"2022-01-15","completion_date":"2025-04-15","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05218655","publication_url":"https://clinicaltrials.gov/study/NCT05218655","title":"An Open-Label, Safety Study for Previously Treated Vatiquinone (PTC743) Subjects With Inherited Mitochondrial Disease","has_exemption":false,"start_date":"2022-06-22","completion_date":"2025-04-15","has_results":true,"results_due":false,"sponsor_name":"PTC Therapeutics","sponsor_slug":"ptc-therapeutics","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT07222904","publication_url":"https://clinicaltrials.gov/study/NCT07222904","title":"Evaluation of the Accuracy of Patient Specific Implant in Fixation of Mandibular Sagittal Split Osteotomy","has_exemption":false,"start_date":"2023-01-10","completion_date":"2025-04-15","has_results":false,"results_due":false,"sponsor_name":"Faculty of Dental Medicine for Girls","sponsor_slug":"faculty-of-dental-medicine-for-girls","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05870124","publication_url":"https://clinicaltrials.gov/study/NCT05870124","title":"Clinical Study Of a Micro-Implantable Pulse Generator For The Treatment of Peripheral Neuropathic Pain (COMFORT 2)","has_exemption":false,"start_date":"2023-04-27","completion_date":"2025-04-15","has_results":false,"results_due":false,"sponsor_name":"Nalu Medical, Inc.","sponsor_slug":"nalu-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06395428","publication_url":"https://clinicaltrials.gov/study/NCT06395428","title":"Haloperidol for Pain Control in Patients With Acute Musculoskeletal Back Pain in the Emergency Department","has_exemption":false,"start_date":"2024-07-09","completion_date":"2025-04-15","has_results":false,"results_due":false,"sponsor_name":"Western Michigan University School of Medicine","sponsor_slug":"western-michigan-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06620744","publication_url":"https://clinicaltrials.gov/study/NCT06620744","title":"Magnetocardiography (MCG) Device Use in Patients With Elevated Troponin","has_exemption":false,"start_date":"2024-09-21","completion_date":"2025-04-15","has_results":false,"results_due":false,"sponsor_name":"SB Technology, Inc.","sponsor_slug":"sb-technology-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06871371","publication_url":"https://clinicaltrials.gov/study/NCT06871371","title":"The Comparison of the Effects of Low and Medium Flow Anesthesia on Haemodynamics, Arrhytmia Risk and Cerebral Oxygenation in Laparoscopic Cholecystomy Cases","has_exemption":false,"start_date":"2025-03-15","completion_date":"2025-04-15","has_results":false,"results_due":false,"sponsor_name":"Umraniye Education and Research Hospital","sponsor_slug":"umraniye-education-and-research-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04675788","publication_url":"https://clinicaltrials.gov/study/NCT04675788","title":"Novel Approaches for Minimizing Drug-Induced QT Interval Lengthening","has_exemption":true,"start_date":"2021-09-02","completion_date":"2025-04-16","has_results":false,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05276570","publication_url":"https://clinicaltrials.gov/study/NCT05276570","title":"A Phase 1/2a Study Evaluating the Effects of ARO-RAGE Inhalation Solution in Healthy Subjects and Patients With Inflammatory Lung Disease","has_exemption":true,"start_date":"2022-06-29","completion_date":"2025-04-16","has_results":false,"results_due":false,"sponsor_name":"Arrowhead Pharmaceuticals","sponsor_slug":"arrowhead-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05078866","publication_url":"https://clinicaltrials.gov/study/NCT05078866","title":"A Phase Ib/II Clinical Trial of Nous-209 for Recurrent Neoantigen Immunogenicity and Cancer Immune Interception in Lynch Syndrome","has_exemption":true,"start_date":"2022-11-10","completion_date":"2025-04-16","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05628233","publication_url":"https://clinicaltrials.gov/study/NCT05628233","title":"A Phase IIa, Multicenter, Randomized, Controlled, Open Label Study to Evaluate the Efficacy of SENS-401 to Prevent the Ototoxicity Induced by Cisplatin in Adult Subjects With a Neoplastic Disease","has_exemption":false,"start_date":"2022-12-30","completion_date":"2025-04-16","has_results":false,"results_due":false,"sponsor_name":"Sensorion","sponsor_slug":"sensorion","status":"ongoing","is_pact":false,"days_late":null}]}